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Abstract 
Secretory proteins start their journey from the endoplasmic reticulum to the Golgi 
undergoing stringent quality control to guarantee the integrity of the secretory proteome. This 
fundamental process is mediated by the coordinated action of numerous resident chaperones and 
enzymes. Amongst these, ERp44 is rather unique in that it is a multifunctional chaperone involved 
in maintaining redox homeostasis and in controlling thiol-mediated quality control and calcium and 
KDEL-Rs signalling. The crystal structure of ERp44 reveals 3 domains, a, b and b’, and a C 
terminal tail that connects domain a with b.  Here we demonstrate that ERp44 activity is regulated 
by the pH gradient existing between the ER and Golgi. The more acidic Golgi pH (about 6.5) 
induces conformational changes in the ERp44 C-terminal tail that simultaneously expose the 
substrate-binding site and RDEL motif. In this way, ERp44 and its client proteins can be retrieved 
to the ER, where the higher pH (about 7.1) likely induces complex dissociation. The region at the 
interface between the C-tail and the substrate binding site is crucial to sense the changes of pH from 
the ER to the Golgi, acting like a sensor, intrinsic in the amino acidic composition of the protein. 
Alteration of Golgi pH induces increased secretion of ERp44 clients, due to a lower retentive 
activity of the chaperone. Moreover, we found that the conserved histidines located at the border 
between the b’ domain and the flexible C-tail are important for regulating ERp44 localization and 
function. Unlike wild type ERp44, mutants lacking key histidines are O-glycosylated in the Golgi 
and in part secreted. Interestingly, co-expression of client proteins restores retention of mutant 
ERp44, suggesting that conserved histidines regulate RDEL exposure in the absence of clients. 
Surprisingly, not all the clients bind ERp44 in the same compartment of the secretory pathway. Our 
data indicate that, depending on their affinity for ERp44 binding site and on the surrounding 
environment (different pH and/or variable cofactor concentration), ERp44-substrate complexes 
form before or downstream the site where O-linked glycosylation takes place. The client-induced 
retrieval mechanisms may allow the distinct and sequential localization of ERp44 interactors along 
the early secretory pathway. Remarkably, endogenous ERp44 can also undergo O-glycosylation in 
physiological conditions. A cyclic oscillation of the amount of O-glycosylated ERp44 is observed 
in stromal endometrial cells during the menstrual cycle, suggesting a pathophysiological role of this 
chaperone in these processes. 
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Part I 
State of Art 
1. Protein folding and quality control 
After synthesis, proteins must rapidly fold to perform their biological activities. Folding takes 
place in three main subcellular compartments: cytosol, endoplasmic reticulum (ER) and 
mitochondria. Each cellular region is equipped with a specific set of chaperones and folding 
enzymes optimized to work in the local conditions. The final result of numerous reactions must be a 
native molecule ready to absolve properly its function. Moreover, structural maturation must be 
completed within a rather short time frame to assess all the cell necessities. In the crowded 
environment of the cell, unfolded proteins are a danger as they may aggregate and become toxic. 
Extensive aggregation is prevented by several proteolytic systems that rapidly dispose of aberrant or 
damaged polypeptides
1
.  
Analysis of the human genome reveals that approximately a third of all open reading frames code 
for proteins that enter the endoplasmic reticulum (ER), demonstrating the importance of this 
organelle for global protein maturation. A considerable fraction of the proteins that enter the ER are 
destined to the extracellular space
2
: these are either secreted by the cell or inserted in membranes, to 
act as ligands and receptors, respectively. Secretory proteins or enzymes and chaperons resident in 
the secretory pathway are synthesized on ER-bound ribosomes, and are co-translationally 
translocated into the ER lumen where they attain their native conformation, before being 
transported to the Golgi and downstream compartments. In a few cases, such as particularly small 
polypeptides or proteins with “weak” signal sequences, proteins can access the ER post-
translationally
3,4
. Being physically segregated from the cytosol, the ER lumen has a distinct folding 
environment, crucial for specific protein modifications that cannot occur in the cytosol, such as 
glycosylation and extensive disulfide bond formation
5
. 
Secreted and membrane proteins are the main devices of intercellular communications. The fidelity 
of ligand–receptor interactions requires that both molecules attain the very conformations that allow 
signals to be properly transmitted and understood. Thus, in the early secretory compartment (ESC) 
the proper protein folding is subjected to a strict quality control (QC) scrutiny and only properly 
folded and assembled proteins can reach the Golgi, where they are further modified, to be 
transported to the extracellular space or to lysosomes (Figure1).  
The logics of protein QC is: 1. Preventing the deployment of aberrant proteins; 2. Retaining 
precursor proteins in an environment suitable for their maturation; 3. Favoring correct assembly by 
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increasing subunit concentration; 4. Reducing the risks of proteotoxicity by inhibiting aggregation 
and degrading terminally misfolded proteins; 5. Maintaining homeostasis in ESC; 6. Developmental 
regulation of protein secretion (like IgM, adiponectin); 7. Storing proteins for regulated secretion 
(plants, adipocytes)
6-9
. ER misfolded proteins are thus recognized and retained by ER chaperones 
and enzymes and eventually routed to degradation by ERAD pathway or autophagy
10, 11
.  
Different studies highlighted the spatial subdivision of the ESC in suitable sub-compartment 
for the retention and biogenesis of different proteins. This division has evolved to cope with the 
myriads of polypeptides that a cell can produce. The entire ESC is equipped with stress sensors that 
are able to sense the amount of misfolded proteins or the increased load of protein folding 
machinery. 3 different sensors (Ire1α, PERK and ATF6) can sense the accumulation of misfolded 
proteins in the mammalian ER and selectively activate a 3 different signal cascades, generally 
called unfolded protein response (UPR). The UPR can selectively inhibit protein entry into the ER, 
increase the folding capacity of ESC machinery by over-expressing specific chaperones or induce 
faster and more efficient protein degradation. The balance between protein load and protein 
degradation is fundamental to prevent cell death.  
 
 
 
 
 
 
 
 
 
 
 
Fig.1 Protein quality control in the early secretory compartment. Proteins destined to the extracellular space or ESC 
resident ones are co-translationally translocate into the ER. Here they start their folding journey under strict quality 
control (QC). Chaperones can be grouped in two different classes according to their specificity and subcellular 
localization. Once entered into ER, nascent proteins can bind Bip or enter the calnexin/calreticulin cycle. The initial 
choice is dictated by N-glycan position. In addition, quality control can act in sequential steps. After the proximal QC, 
proteins (especially multimeric ones) can undergo distal check point in ERGIC-cisGolgi. This “second” quality control 
can mediate protein concentration and selective export of oligomerized species. While the proximal QC is based on 
protein retention, the distal QC can imply substrate retrieval to ER for another round of folding or for degradation. 
 
Proximal QC Distal QC 
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2. Focus on protein folding in the early secretory compartment 
In the ESC protein folding starts during synthesis, as a vectorial process. The journey of a protein 
entering the mammalian ER starts with the recognition of a signal sequence, typically but not 
exclusively found at the N terminus of the nascent protein
5
. Signal sequences are quite variable, but 
generally have 6 to 12 hydrophobic amino acids flanked by one or more positively charged 
residues. This amino acidic code is recognized by signal recognition particle (SRP)
12,13
 with the 
resulting ribosome/nascent chain/SRP complex binding to the ER membrane via the SRP receptor. 
The ribosome/nascent chain complex is then directed toward a proteinaceous pore in the ER 
membrane called the Sec61 translocon:  this allows the translocation of the growing polypeptide 
chain across the membrane and into the ER. Upon co-translational translocation, nascent secretory 
proteins enter the crowded environment of the ER lumen and soon begin to fold into more stable, 
lower energy, conformation(s)
14
. It is therefore important to realize that protein folding may well 
influence post-translational modification and the other way around. 
The ER is unique in sustaining a set of covalent modifications, which include removal of the signal 
sequences, disulfide bond formation, N-glycosylation and GPI addition. A plethora of enzymes and 
assistants are found in the early secretory pathway (ESC), specific for catalyzing each step. The 
transport from a platform to another must follow the execution of a given step. The time allocated to 
the latter, however, must be precisely controlled in order to allow efficiency and prevent jams along 
the line. Glycoproteins have been analyzed in great detail as a prototypic example of labor 
organization in the ER protein factory. In fact, the sequential modifications of the oligosaccharides 
provide an elegant solution to dictate and time the manufacture of cargo glycoproteins. N-
glycosylation involves binding of a preformed oligosaccharide (Glc3Man9GlcNAc2) to asparagine 
side chains in the sequence NXS/T, where X is any amino acid other than proline
15
. The sugar 
moieties are then progressively trimmed by resident enzymes of the secretory pathway. The so 
called proximal QC is thus composed of two well characterized ER folding pathways: the enzymes 
involved in the so called clareticulin - calnexin (CRT-CNX) cycle and Bip (also called GRP78) 
(Figure 1).  
CNX and CRT retain substrates with immature glycans in the ER, prevent their aggregation, and 
promote oxidative folding via interactions with ERp57
16-19
. In particular, the UDP-glucose 
glycoprotein glucosyltrasferase (UGGT) acts as a folding sensor by producing mono-glucosylated 
proteins that can interact with CNX and CRT. The subsequent removal of the terminal glucose, 
glucosidase II dissociates the substrate from CNX/CRT for a novel round of inspection by UGGT
20
. 
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Bip, on the other hand, is an abundant ER chaperone of the hsp70 family which recognizes exposed 
hydrophobic patches and is also involved in ER signalling (UPR)
21,22
. This chaperone is composed 
of an N-terminal ATPase domain and a C-terminal domain with affinity for hydrophobic 
patches
23,24
. The affinity for substrates depends on ATP binding at the N-terminal domain. When 
ATP is hydrolyzed to ADP, a conformational change occurs, which determines substrate release. 
Bip substrates can thus undergo cycles of BiP binding and release, depending on ATP hydrolysis
25
. 
Owing to the weak BiP ATPase activity, hsp40-like co-chaperones containing J domains (ERdj) can 
play a key regulatory role
1,26
. 
Very rarely glycoproteins are found to bind simultaneously to BiP and CNX or CRT. Therefore, it 
seems that a given glycoprotein has to choose between either BiP or the CNX/CRT cycle. The 
initial choice is dictated by the localization of the N-glycans: the closer these are to the N-terminus 
of the nascent protein, the higher the tendency to use CNX as a chaperone system
27
.  
Some proteins require assembly into complexes, and provision of lipids for ER membranes and the 
regulation of cholesterol content are also important considerations
5
. If the first attempts to fold fail, 
the protein can shift to the alternative pathway downstream the ER. To ensure orderly ER exit, 
proteins need the provision of sugars for glycoproteins, the availability of cofactors (particularly 
calcium), and the appropriate formation of disulfide bonds. The default pathway for ER exit to the 
Golgi is via COPII-coated vesicles
28
. COPII-coated vesicles subsequently fuse to form the ER-
Golgi intermediate compartment (called ERGIC). Therefore, after a proximal QC, proteins can 
undergo distal QC checkpoints in ERGIC and Golgi (Figure 1). While many chaperones and 
enzymes reside stably in the ER, some particular proteins (like ERp44) may cycle through the 
earlier stacks of the Golgi or between ERGIC and cisGolgi via the KDEL receptor, either unbound 
or with client proteins
5,29,30
. This model could mediate cargo concentration in a specific 
compartment and selective binding of different protein species depending also from the surrounding 
environment. 
While proximal QC can rely on simple retention, the distal checkpoints likely imply substrate 
retrieval to the ER, either for further attempts to fold, or for retro-translocation and degradation. In 
the ER-Golgi intermediate compartment, ERGIC 53, a protein with lectin activity is able to cycle 
between the ER and the ERGIC
31
 and binds high-mannose cargoes, facilitating their forward 
transport. Further mannose trimming in the ER may favor degradation, possibly also because 
reducing the hydrodynamic volume of substrate glycoproteins could facilitate their retro-
translocation
1
. ERGIC53 works together with MCFD2, a soluble calcium-dependent protein, to 
capture its cargo dynamically
32
. Various inactivating mutations in the ERGIC53 gene (LMAN1) 
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and in the MCDF2 gene lead to a multiple coagulation factor deficiency called MCFD1
33
 because 
of a failure to package the heavily glycosylated Factor V and Factor VIII proteins
34
. 
 
2.1. Oxidative folding 
One feature of the proteins folded in the ER is the oxidation of free thiols on cysteines to 
disulfide bonds. This is done by means of a process known as oxidative folding
35
. Disulfide bond 
formation is supported in the oxidizing environment of the ER, which has a relatively low ratio of 
reduced to oxidized glutathione (GSH:GSSG between 1:1 and 3:1)
36,37
. In fact, in terms of ionic 
composition and redox potential, the ER is similar to the extracellular space, providing an ideal 
folding test bench before exiting from the cell. The higher ratio between reduced and oxidized 
glutathione however is not sufficient to guarantee the efficient power to oxidative folding, which 
often implies both disulfide bond de novo formation and isomerization
38
. On the other hand, an 
hyper-oxidizing environment in the ER lumen might prevent the correct folding of proteins with 
multiple disulfide bonds and decrease protein stability, promoting misparing, which can induce 
protein misfolding
1
. 
The transition from free thiols to disulfides is based on the dynamic and concerted formation, 
reduction, and reshuffling of disulfide bonds that favor the introduction of native (and therefore 
functional) disulfide bonds. In addition, the free thiols on proteins can be exposed to a competing 
H2O2-mediated oxidative process that produces oxygenated thiol derivatives, like sulfenylated 
proteins
35
. This type of derivatives can be transient intermediates in the formation of more stable 
disulfides or precursors of higher oxidized sulfur oxides (sulfinic and sulfonic acids); they can also 
react with GSH to produce S-glutathionylated proteins
39
. It is thus clear that the intricate disulfide 
relay requires enzymatic assistance: a specialized class of enzymes of the protein disulfide 
isomerase (PDI) family in fact has evolved to promote the efficient formation of native disulfides in 
folding ER proteins. PDIs, through a redox-active thioredoxin-like catalytic domain (CXXC), 
directly introduce disulfide bonds into reduced client proteins being thus finally reduced 
themselves40. The endoplasmic oxidoreductins 1 (Ero1 α and β) re-oxidize and reactivate the 
thioredoxin-like (TRX) domain of PDI for a new cycle of oxidative protein folding, transferring 
electrons to molecular oxygen (the final electron acceptor in aerobic condition) thanks to their 
cofactor flavin adenine dinucleotide (FAD): as a consequence Ero1 activity produces H2O2
41-46
. In 
particular PDI consists of four TRX domains: the two lateral domains (a and a0) are endowed with 
oxidoreductase activity, while the two central ones, b and b0, provide a hydrophobic surface suited 
to bind and present nascent proteins to the active sites in a and a0. This overall structure is likely 
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important for the redox dependent chaperone function of PDI
47,48
, particularly with terminally 
misfolded proteins, which must be reduced before dislocation to the cytosol for proteasomal 
degradation
49-52
.  
The final balance of oxidative folding is that one molecule of H2O2 is produced for every 
disulfide bond formed
53
. The efficient disposal of H2O2 is done by means of ER peroxidases which, 
as their name suggests, are dedicated to degrading H2O2. The mammalian ER is endowed with three 
known peroxidases Prx4, GPx7 and GPx8
54-56
. Peroxiredoxin 4 (Prx4) is the oldest of these in 
evolutionary terms and is more expressed in secretory tissues. Prx4 has the characteristic of 
coupling hydrogen peroxide catabolism with oxidative protein folding. This enzymatic arrangement 
involves the ingenious use of H2O2 as a substrate to streamline protein metabolism (Figure 2). 
Recent studies demonstrated that oxidized Prx4 clearly transfers disulfide bonds much more 
efficiently to PDI
57,58
, ERp46
59
 and possibly other ER oxidoreductases than to GSH
60
.  
Eight mammalian GPxs are known and among them only three are CysGPxs (GPx5,7 and 8). In 
particular GPx 7 and 8 are ER monomeric ER enzymes. Whereas GPx7 possesses a cleavable leader 
sequence at the N terminus, GPx8 is a transmembrane protein with a short N terminal cytoplasmic 
tail. Both Gpx7 and 8 are retained into the ESC thanks to REDL and KEDL motif which are 
recognized by KDEL-Rs in the distal compartments
61
. In analogy to Prx4, GPx7 and 8 can act as 
PDI peroxidases by using them as electron donor. In particular, it’s clear that Prx4 preferentially 
oxidizes the domain a0 of PDI while GPx7 the domain a in the active site
57,62
. The model proposed 
for GPxs is based on their ability in coupling the reduction of Ero1α derived H2O2 to H2O with the 
introduction of a second disulfide bond into a PDI family member
56
. Thus these enzymes protect 
nascent proteins from an alternative oxidative fate, and cells from the consequences of having 
misfolded proteins. Moreover, as Ero1 enzymes, also Prx4 lack a C-terminal ER retention signal 
and depends on ERp44 for its intracellular localization: when PDI is down-regulated, in fact, Ero1α 
and Prx4 are retained by ERp44 in the distal ESC
63
. 
Over the last years, many other ER-resident PDI-like oxidoreductases have been 
characterized in mammalian cells. There are about twenty proteins in the human PDI family 
containing up to five thioredoxin domains and from zero to four redox-active CXXC like 
motifs
40,6466
. The abundance of PDI family member in the ESC confirms that the proper disulfide 
bond formation is crucial for nascent protein folding and for protein complex composition (like 
IgM)
67,68
. The reactivity of thiol groups can favor the formation of mixed disulfides with PDI, 
ERp44 and other ER-Golgi resident proteins
69-71
. The thiol-dependent retention mechanisms, 
originally described in the developmental control of IgM
72
, and HMW adiponectin secretion
73
 is 
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extended to retention of ESC soluble molecules that lack retention motifs but that need rest inside 
the compartment to explain fundamental functions (like Ero1α, Prx4 and Sumf1). 
 
Fig.2 Disulfide bond formation. Disulfide bond formation leaves PDI in a reduced state (PDI
red
). Ero1 can re-oxidaze 
the active site of PDI and renders the chaperone ready for another reaction. The two electrons received by PDI are then 
assed to molecular oxygen producing H2O2 . PRX4 can use the H2O2 produced by Ero1 mediated oxidative folding to 
catalyze another cycle of oxidative folding.     
 
3. Zinc contribution to cellular processes 
Zinc (Zn
2+
) is the second most abundant trace element in living organisms
74
 and is the most 
abundant trace element in cells. Interestingly, Zn
2+ 
is clearly not a trace element from the 
perspective of the cell
75
, as it is required for an immense number of catalytic, structural, and 
regulatory functions in specific subcellular compartments, including gene transcription in the 
nucleus
74
, ATP production and apoptosis in the mitochondria
76
, enzyme activation in the secretory 
pathway
77
 and microtubule formation
78
 and cell signaling in the cytoplasm
79
. The intracellular 
amount of zinc can be divided in different pools: the zinc bound to macromolecules, the zinc stored 
inside vesicles, exchangeable or mobile zinc and zinc bound to metallothionein (MT), that can be 
released in a redox dependent way
80
. Most of the intracellular zinc is bound with high affinity to 
proteins including GSH, via cysteine, histidine and diphosphate molecules. An excess of mobile 
zinc can be toxic for the cell, in part due to its ability to be easily coordinated by endogenous 
proteins and peptides. However, up to millimolar concentration of mobile zinc is stored in synaptic 
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vesicles in the mossy fibers of the hippocampus, which is proposed to play a role in learning and 
memory formation during neurotransmission
81,82
. Recently, zinc mobilization into and out the 
intracellular organelles, including ESC, has received great interest. Proteome analysis revealed that 
about 10% of the known proteins have a potential zinc-binding motif, which confirms the 
importance of this ion
83
. Alteration of the zinc homeostasis is crucial in several neurodegenerative 
pathologies including Alzheimer’s and ischemia82 and a decreased concentration of mobile zinc in 
prostate serves as an important marker for early diagnosis of prostate cancer
84
. In vertebrates two 
are the major family of transporters, Zip (SLC39A) and ZnT (SLC30A), which are involved in zinc 
transport and homeostasis. Zips transport zinc into the cytosol from extracellular or intracellular 
compartments, while ZnTs export cytosolic zinc to extracellular or intracellular compartments
85,86
. 
Structurally, Zips have eight transmembrane domains with N- and C-termini on the non-
cytoplasmic face. In contrast, the majority of ZnTs consist of six transmembrane domains (ZnT5 is 
the exception with nine additional transmembrane domains) with N- and C-termini within the 
cytoplasm. Transmembrane domains 3 – 4 and 4 – 5 on Zips and ZnTs, respectively, contain a long 
loop with a histidine-rich domain that is thought to facilitate metal binding. Zinc transporters 
function by forming both homo and hetero dimers, like ZnT5-ZnT6
77
. Both Zips and ZnTs are 
expressed in cell and tissue-specific manners and are developmentally regulated and localized in 
different intracellular compartments, as clearly demonstrated for mammary gland
87
. In 
mammalians, about 24 Zip/ZnT transporters are known and half of them are localized in secretory 
and endosomal - lysosomal compartments, underlying the importance of this subcellular regions as 
zinc storage sites
87
.  
Among the Zips, Zip7, 11 and 13 are located in ESC: in particular Zip7 is present at the ER 
membrane and is involved in zinc mobilization from ER to cytosol. When Zip7 is phosphorylated 
by CK2, it can activate a cytosolic signaling cascade which induces phosphatase inhibition
88
. A to 
ZnT transporters, instead, ZnT4, 5, 6 and 7 are all suggested to maintain zinc secretory pathway 
homeostasis and regulate zinc-requiring enzyme activities
89,90
. Zinc has no direct redox activity but 
it can interact with sulfur in cysteine residues under reducing conditions and the nature of the 
sulfur-zinc binding allows a rapid association/dissociation of the metal in response to cell needs. In 
fact, zinc can be released by NO or H2O2, oxidized glutathione and other oxidant species. For these 
reasons, zinc is known to contribute to cell redox balance regulating oxidant production, glutathione 
metabolism and the overall protein thiol redox status and redox signaling
87
. 
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4. Retention and selective secretion: role of chaperones and environment. 
In a complex multicellular organism, different cell types engage in specialist functions, and as a 
result the secretory output of cells and tissues varies widely. Whereas some quiescent cell types 
secrete minor amounts of proteins, tissues like the pancreas, which produces insulin and other 
hormones, and mature B cells, which secrete antibodies, place a great demand on their ESC
37
. 
Unless retained by interactions with resident proteins, a folded protein could exit from the ER and 
be subjected to selection for transport to the plasma membrane
5,91
. Many proteins are actively 
transported out of the ER by interaction with specialized export machineries
92,93
. Export from the 
ER occurs at ER exit sites
94
 (ERES), where budding of COPII-coated vesicle takes place.  
The exit from the ER and the entry into ERGIC and then Golgi complex expose the nascent proteins 
to different environment with specific ions concentration (Ca
2+
, Zn
2+
 and H
+
) and different 
chaperones and enzymes.  
 
4.1. Role of ESC pH gradient 
The maintenance of an appropriate pH within the different compartment is a constant challenge 
for all the living cells
95
. Cells have evolved a variety of proton translocation devices (proton pumps) 
thus produce a proton gradient used to regulate protein degradation, activity and ATP production. 
The pH varies along the ESC compartment with acidification increasing progressively from ER to 
lysosomes (Figure 3). The pH of ER is in fact near the neutrality (7,0-7,1)
96,97
 while acidification 
develops along ERCIG-Golgi complex and is maximal at the transGolgi network (TGN, pH 6,0-
5,8)
98,99
. The acidic pH of organelles is generated primary by vacuolar (V) H
+
-ATPases, which 
actively pump protons in presence of Mg
2+
 and ATP. The proton gradient thus generated can then 
be used to drive a variety of second active transport processes. Due to its electrogenic nature, proton 
pumping can be limited by the generation of a transmembrane voltage. In order to avoid this 
phenomenon and to sustain the rapid acidification of certain compartment, Cl
-
 fluxes are used 
98
. 
GPHR is one of the voltage-dependent anion channel present at Golgi complex level that acts as 
counterion to proton pumps and is involved in maintaining a lower pH with respect to the ER
100
. 
The correct acidification of distal ESC is known to be crucial for protein trafficking, processing, 
glycosylation and recycling
100-103
.       
In mammalian cells, one of the best characterized transporters is ERGIC-53, a hexameric 
transmembrane lectin
104
 that derives its name from being particularly abundant in the ERGIC. 
ERGIC-53 is described to capture high-mannose glycoproteins in the ER, and release them in the 
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ERGIC in a Ca
2+
 and pH-dependent manner
105
. It has been suggested that another lectin, VIPL, 
binds de-glucosylated cargoes exiting the CNX/CRT cycle, protecting them from de-mannosylation. 
The cargo is then passed to ERGIC-53, perhaps owing to its hexameric structure, and exported 
toward the Golgi
105
.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.3 pH of endocytic and secretory compartments. Organelles rapidly acidify as they progress along the secretory and 
endocytic pathway. Here, the pH gradient is represented with a color scale from blue to yellow. The nascent protein (in 
light violet) is co-translationally translocated into the ER lumen at pH 7,0-7,1 (in blue) and continues its trip where can 
be transported to secretory vesicles (in purple, pH 5,5) or to lysosomes (in yellow, pH<5,5).   
 
4.2. KDEL Receptor role in protein recycling and inter-organelle signaling 
The flow of proteins leaving the ER has been estimated to be between 1-5% of the total ER 
volume per minute
106
. In this respect, the rates of traffic flow across the ESC must be precisely 
coordinated to avoid structural and functional disruption of the system. In order to control the 
protein flow within the ESC, different stations/organelles receptors and signaling components are 
used and take part of the so called “endomembrane” signaling pathway. Some signaling proteins 
could be in transit through the Golgi complex and then directed to the plasma membrane, others can 
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be retained in the ESC thanks to a recycling mechanism. The endomembrane signaling can be 
defined as a stimulus generated in a specific intracellular organelle that is targeted to a different 
compartment within the same cell
107
. This mean that protein traffic itself can initiate the 
endomembrane signaling, sustaining both an anterograde (cis-transGolgi and Golgi-plasma 
membrane) and a retrograde (ERGIC/cisGolgi-ER) protein transport, depending on the cell needs.    
In the late 90s it was discovered that the KDEL motif at the carboxyl terminus of many soluble and 
membrane proteins is a way to impair ESC resident protein secretion, retro-localizing them to the 
ER
108
.   
The KDEL-receptors (KDEL-Rs) are seven transmembrane proteins of 26kDa with a 3D structure 
that resembles that of G protein-couple receptors (GPCRs)
109
. They can recognize and bind proteins 
that contain KDEL like motifs at the ERGIC-Golgi level. Thanks to this interaction, KDEL-Rs are 
activated and can thus dimerize and recruit COPI-trafficking machinery to retro-transport and 
release the client into the ER. From this ESC station the KDEL-Rs can again shuttle between ER-
Golgi complex
110
. Different experiments demonstrated that the binding to KDEL like motif by the 
receptors requires an acidic pH as the one encountered in the Golgi. The KDEL-Rs are thus able to 
bind KDEL sequences in the Golgi and retrieve their cargo back to the ER, where the higher pH 
favors their release. In this way the receptors can return to their original localization
111
.         
Recent studies uncover the role of KDEL-Rs in activating signaling by carriers arriving at the Golgi 
from the ER
109,112,113
. The triggering signal is provided by ER chaperones containing KDEL like 
motif. KDEL-bearing chaperones can be divided in 2 groups. Most of them bind the ER matrix and 
seldom reach the Golgi; some, instead, diffuse more easily and can exit the ER. It seems that 
ERp44, a chaperone active at ERGIC-Golgi level, is a member of the second (Luini’s group, 
personal communication).   
At the Golgi level, KDEL-Rs can activate a pool of Gq and Gs signaling proteins
109,112
, adapting 
Golgi traffic to input from the ER. Thus, KDELRs act as traffic sensors and activate controllers that 
in turn elicit responses eventually adapting transport efficiency to load volume. Moreover, the Golgi 
complex hosts many molecules that are potentially involved in diverse cell functions like cell 
motility and growth and cell cycle. The read out of the KDEL-Rs activation has thus many 
implications in a wide range of cellular processes. The proposed model is the following: cargo 
vesicles leave the ER and reach the downstream compartments (ERGIC and Golgi complex) 
carrying also chaperones that have KDEL-like motif and that can be recognized by KDEL-R. This 
interaction triggers a specific response activating the PKA pathway (Gs pool) for the retrograde 
transport or Src signal cascade for the anterograde flow (Gq pool)
114
 (Figure 4). 
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Fig.4 Model of KDEL-R signaling in the ESC. Chaperones containing KDEL like motif (blue molecules) leave the ER 
and on the arrival to ERGIC or Golgi complex, they bind KDEL-R (in red), triggering Src response (yellow star) for the 
anterograde transport to transGolgi and plasma membrane or PKA (in orange) for the retrograde translocation to the 
ER. 
5. ERp44: structure and function of a multifunctional chaperone in the ESC 
ERp44 is a chaperone of the PDI family, highly expressed in many secretory tissues like 
pancreas, urinary bladder, salivary gland, stomach, duodenum, testis, prostate, seminal vesicles, 
ovary, placenta, and bone marrow (see www.proteinatlas.org for detailed information). Moreover, 
ERp44 protein levels can be modulated in cancer tissues as reported for liver cancer where this 
chaperone is over-expressed or for testis cancer, where ERp44 expression is down regulated 
compared to normal tissue (see www.proteinatlas.org for detailed information).  
ERp44 was discovered in 2002 as a covalent partner of the oxidases Ero1α and β115. By using in 
silico modelling it was predicted that ERp44 structure can be largely superimposed on PDI active 
domains even if at amino acidic level there are important differences. In particular, there is a CFRS 
motif in the substrate binding site (SBS) of ERp44, so the second cysteine residue of the CXXC 
motif typical of PDI is absent. However, deep in the ERp44 SBS, there’s an additional cysteine 
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(C63) that is not present in other PDI family members
115
. This residue is present on a loop 
juxtaposed to C29, suggesting its putative role as accessory binding residue.   
Subsequently, the X-ray analysis of human ERp44
116
 revealed a clover like structure composed of 3 
thioredoxin-like domains a, b and b’ and a C-terminal tail (C-tail) that connects  b' and a domains 
(Figure 5). In the last part of the C-tail it is present a KDEL like motif that plays an important role 
in preventing ERp44 secretion by binding KDEL-Rs. For this reason ERp44 is also studied as a 
possible trigger of KDEL-R signaling. Even if the protein is retrieved by KDEL-Rs to ER, 
endogenous ERp44 accumulates in the distal ESC (ERGIC-cisGolgi), while its over-expression 
induces ER localization. This peculiar scheme of compartmentalization depends in part on 
interactions with ERGIC-53, and reflects a specific role of ERp44 in distal QC
71
. In particular cell 
types, like pre-adipocyte, the ERp44 localization can change from ERGIC-cisGolgi to ER 
depending on the state of differentiation and so reflecting the needs of preventing misfolded or 
unfolded protein secretion.  
Thanks to the C29 present in the domain a, ERp44 binds and retains substrates of thiol-mediated 
retention (TMR)
72
, including unassembled IgM subunits, SUMF1, adiponectin (APN)
117
 but also 
soluble clients that must be retained into the ESC for maintaining the redox homeostasis like the 
oxidases Ero1α and β45,115,118 and Prx4119,120. The C-tail movements are crucial for the simultaneous 
exposure of both the substrate binding site (containing C29) and the RDEL motif. In fact, the 
formation of a disulfide bond between C29 and C369 in T369C mutant hinders the accessibility of 
clients, like Ero1α, to the active site of ERp44 but also the impairs the KDEL-Rs binding to the 
final RDEL motif inducing both client and ERp44 secretion. Moreover, the amount of ERp44 
T369C in the spent medium is similar to the one detected when the mutant lacking the final RDEL 
is over-expressed (ERp44ΔRDEL).  
Substitution of C29 with alanine (C29A) renders ERp44 less active as a covalent binder but it is still 
able to retain clients with high affinity for the SBS of the chaperone (non-covalent binding). So 
ERp44 is able to bind covalently and non-covalently its clients and impair their secretion. 
Surprisingly, removal of the C-tail (ERp44 ΔTail) doesn’t induce ERp44 secretion but enhances the 
binding capacity of the chaperone
116
. Therefore, the C-tail is fundamental not only for the retention 
but also for the specificity of binding (choosing the proper client in a specific compartment).  
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Fig.5 3D model of ERp44 closed structure. The picture highlights the different domain of ERp44 with different colors 
(domain a in light violet, domain b in blue and domain b’ in light brown, respectively) and the C-tail in green. C29 and 
C63 in white are located in the substrate binding site present in the domain and covered by the tail in the closed 
structure. Red letters (A, A’ and B) point at the position of the resolved histidine residues. From residue 332 to 350 the 
crystal structure is not resolved  by x-ray probably due to the extreme flexibility of the loop (flexible loop) as the five 
last C –terminal DRDEL residues. 
 
5.1. Role of ERp44 in IgM polymerization and secretion 
IgM polymers are planar multimeric molecules assembled in the ESC and secreted by plasma 
cells. Each monomer must be correctly folded, bend and expose the complement binding sites to be 
fully functional. Secretion of non-polymerized subunits with not fix complement could inhibit lytic 
antibody activity and, moreover, misshaping polymers could activate antibody response in absence 
of a real antigen
117
. However, plasma cells have to produce and secrete thousands of functional Ig 
per second to face possible organism injury. Thus production of antibodies keeps the protein quality 
control machinery very busy. The biogenesis of IgM polymers starts from the folding of heavy 
chain (µ) and proceeds with the paring with the light chain (µL) and µ2L2. This first part of the 
process occurs rapidly in the proximal ESC thanks to the help of Bip that binds the first constant 
domain of heavy chain (CH1). The polymers formation is slower and it is peculiar of certain cell 
types like plasma cells. Once passed this first step of QC, µ2L2 can be bound by ERGIC-53, whose 
hexameric structure provides a planar platform for the IgM assembly. ERGIC-53 binds 
preferentially N-glycan located in the conserved C-terminal tailpiece of µ chain (µtp) upstream the 
C575 where ERp44 is able interact
121
. Previous studies showed that ERp44 and ERGIC-53 amount 
 
C 
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increases during plasma cell differentiation in line with the pattern of polymerization of IgM and 
over-expression of ERp44 in Hela cells prevents un-polymerized subunit secretion in favor of 
polymer formation. In this scenario, ERp44 can help IgM polymerization by providing oxidative 
power via Ero1α recruitment, increasing concentration of  subunits ready to polymerize in the right 
place and interacting directly with ERGIC-53
117
.       
 
5.2. ERp44 can regulate the calcium flux via IP3R1 
 
Ca
2+
 signaling plays a fundamental role in a plethora of biological functions
122
. Two main 
sources of Ca
2+
 are the plasma membrane and the ER. Inositol 1, 4, 5-trisphosphate receptors 
(IP3R) are channels that upon binding to IP3 release Ca
2+
 and allow signal propagation
123
. Three 
IP3R isoforms are known, IP3R1, IP3R2 and IP3R3, with different tissue distributions. The activity 
of IP3Rs is regulated on both sides of the ER membrane. In particular, ERp44 was shown to bind 
specifically to the variable region of the 3
rd 
luminal loop (L3V) of ER luminal side of IP3R1. The 
interaction inhibits the channel activity in a pH, redox and Ca
2+ 
ER-dependent manner
124
. The 
interaction between ERp44 and IP3R1 is not related to the exposure of C29 but C160 and C212 
present in the domain b of ERp44 seem to be crucial for the interaction
125
. Further studies from our 
laboratory indicated that Ero1α enhances IP3R1 activity in at least two ways: by favoring its 
oxidation and by competing with it for ERp44
126
. Both events inhibit the binding of ERp44 to 
IP3R1, and favor Ca
2+
 efflux from the ER. This is in line with the data showing that Ero1α is able to 
induce apoptosis in stressed macrophages
127
. Therefore, ERp44 is the link between thiol-mediated 
quality control, redox and calcium homeostasis.  
 
5.3. ERp44 and the secretion of high molecular-weight adiponectin  
 
Adipocytes are endocrine cells that are known to store lipids and secrete many molecules 
fundamental for the energy metabolism, like adiponectin (APN). This hormone stimulates fatty acid 
oxidation, suppresses hepatic gluconeogenesis, increases insulin sensitivity, has anti-atherogenic 
effects and acts to counter the effect of TNFα128. It is clear that the production of APN increases 
about 100 fold during adipocytes differentiation and this molecule seem to play a crucial role in 
type II diabetes, obesity and cardiovascular diseases
129,130
. Nascent adiponectin is a monomer of 30 
kDa composed of a collagenous domain and a globular C-terminal domain. In the ER the protein is 
able to multimerize and form trimers (low molecular weight species). While trimers are held 
together by non-covalent interactions, hexamers and high molecular weight species (18-emers) are 
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formed thanks to disulfide bond formation via C39
131,132
. So APN undergoes sequential quality 
control in the ESC. In adipocytes ERp44 is over-expressed during differentiation and, moreover, it 
changes localization from distal ESC to ER, where it co-localizes with adiponectin. This suggests 
that ERp44 is crucial for the formation of high molecular weight adiponectin species. Over-
expression of ERp44 impairs the secretion of low molecular weight APN in a dose dependent 
manner whereas depletion of this chaperone enhances their secretion. Equally important is also 
Ero1α contribution to the process. In fact, upon over-expression of Ero1α less ERp44 is associated 
with APN 
73
. So these data confirm that Ero1α is a high affinity partner of ERp44 that can compete 
with other clients in binding. ERp44 is involved in different regulatory circuits important for 
metabolic homeostasis.  
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Aims of the project 
In order to dissect the mechanisms underlying the multifunctional activity of ERp44, I have focused 
my attention on understanding how ERp44 is tightly regulated and associated with different clients 
in the early secretory compartment, using novel and innovative technology. 
 
Aim I: ERp44 activity and regulation 
A combination of crystallography, molecular dynamics, biochemical and cell biological 
assays reveal that ERp44 is able to cycle between ESC and perform different functions in each 
station. ERp44 is mainly localized at ERGIC-cisGolgi compartment at the steady state but it can be 
seen in the ER whenover-expressed. Moreover, the C-tail movements of ERp44 are crucial for 
retention of clients, selectivity in binding and retrieval of the chaperone itself. Preliminary data 
showed that C-tail movements can be regulated by the differential pH existing in each ER-Golgi 
complex stations (Figure 6). These finding indicated that the pH gradient along ESC coordinately 
regulates the activity of ERGIC-53, ERp44 and KDEL-Rs, coupling efficiency and fidelity of 
protein secretion.   
Indeed, ERp44 binds much better its clients at pH 6.5 (as in the cisGolgi) than at 7.1 (as in the ER). 
It is hence tempting to speculate that the lower pH of the cisGolgi leads to C-tail opening thereby 
exposing both the active site and RDEL motif, allowing KDEL-Rs (that also shows pH dependency 
in vitro) 
111
  to retrieve ERp44-client complexes into the ER. In this organelle, the higher pH might 
favor substrate dissociation. Taking in account all the previous data, we decided to investigate how 
ERp44 is able to exploit the pH gradient existing in the ESC. 
 
Fig.6 ERp44 activity is pH dependent in vivo. GPHR silencing induces 
Golgi pH basification and specifically inhibits retention of ERp44 clients. 
Aliquots from culture media (Secretion) were collected from HeLa 
transfectants expressing Ero1α (upper panel), adiponectin (APN, lower 
panel) and subjected (+) or not (-) to GPHRi. Co-expression of ERp44 
and its partners impair their secretion (both Ero1α and APN; compare 
lanes 1 and 3), while Golgi pH basification induced client secretion 
(compare lanes 1-2 and 3-4).  
 
 
 
Life of a chaperone in the ESC 
 
19 
 
Aim II: ERp44 association with partners and identification of novel ones 
ERp44 cycles between ESC stations and mitochondrial associated ER membranes (MAM), 
binding -in addition to its clients- ERGIC-53, IP3R1 and KDEL-Rs. So during its “journeys” this 
chaperone has to be able to discriminate between different possible partners and bind the right one 
in a specific compartment. ERp44 mutants without the C-tail or with a partial deletion of it (Δβ16) 
are known to bind more covalent cargoes but with less specificity
116
; moreover,  they are not 
secreted but blocked in the ER. On the other hand, mutation of C29 into alanine impairs covalent 
binding to clients but not the retention of high affinity partners like Ero1. Thanks to different 
ERp44 mutants we wanted understand where, along the secretory pathway, the interaction with 
known ERp44 partners (Ero1α, Sumf1, Prx4, Ig-µΔCH1 and APN) occur and the role of ERp44 
domains in the differential binding. As ERp44 has multiple interactions in different cellular 
compartment, by using special tag we expect to learn more about the physiology of ERp44 cycling. 
With protein precipitation assays, we can isolate novel ERp44 substrates, activity regulators and 
MAM-ER-Golgi complex resident proteins that can dictate ERp44 localization. 
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Results 
How ERp44 senses the pH 
In silico and structural analysis predict C29 has a role in the pH sensing activity of ERp44. In 
particular, molecular modelling suggested that specific residues (S32, R98, T368) are crucial to 
contribute in maintaining lower the local pKa value of C29 in the active site and favors the closed 
conformation (Figure 7). At higher pH the differential protonation of C29 can induce the C-tail 
opening, favoring the client binding.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.7 Schematic representation of the amino acidic environment around C29. The panel shows a closer view of the 
active site C29 and of the last part of the C-tail, highlighting interactions between C29 and neighboring residues shown 
as a stick models. Hydrogen bonds between polar atoms are shown as dashed lines. The β16 strand is colored in pink.  
To test these prediction, both in vitro and in vivo assay were performed whit ERp44 mutants. In 
vitro, MalPEG binding assay demonstrated that: 
a) ERp44 wt can covalently bind maleimide when the C-tail is open, so in a pH dependent 
manner; 
b) the binding is mainly to C29 present in the active site;  
c) altering the side chain of S32, R98, T369 renders ERp44 constitutively accessible to MalPEG  
and abolishes the pH sensitivity of the reaction;  
d) partial deletion of the C-tail (β16 strand, represented in pink in Figure 7) give similar results to 
the one obtained with residues substitution, supporting S32A, R98Q and T369A mutants adopt 
the open C-tail conformation (Figure 8). 
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Fig.8 pH dependent binding of maleimide to ERp44 variants. In vitro MalPEG binding causes reduced ERp44 gel 
mobility (U stands for unbound ERp44) and was analyzed at various pH to determine changes in the accessibility to 
C29 in the active site. While more MalPEG is bound to the C29 at lower pH, the indicated mutants seem to show an 
increased pH independent MalPEG reactivity.  
 
The phenotype of the above mutants was also investigated by using different in vivo assays.  
In line with the previous results, mutation of the residues expected to affect the protonation of C29 
(S32, R98, and T369) dramatically increased the tendency of ERp44 to form covalent complexes 
with client and partner proteins, reaching levels comparable to a mutant lacking the whole β16 
strand (ERp44 Δβ16) and the fraction of covalently bound partners doesn’t change upon 
basification of Golgi pH (GPHR silencing) (Figure 9). 
Not only the covalent binding but also the client retention ability of ERp44 is altered upon 
residue substitution. In particular, clients like APN are less retained by S32A, R98Q, T369A and 
C29A mutants and in a pH independent way.  
 
Fig.9 In vivo analysis of pH sensor residues. HeLa transfectants 
expressing the indicated ERp44 mutants were subjected  (+) or 
not (-) to GPHR silencing (GPHRi). Aliquots of lysates were 
resolved under non-reducing 
conditions and decorated with anti-HA antibody that recognize 
only the over-expressed ERp44. The black arrow points to 
monomeric ERp44. While the amount of ERp44 wt engaged in 
covalent complexes goes down after Golgi pH basification 
(compare lanes 1-2), the mutants have higher binding capacity 
in a pH independent manner (lanes 3-4 and 5-6). 
   1      2      3      4           5       
6  
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Role of conserved histidine residues in ERp44 activity 
By looking at ERp44 amino acidic sequence an histidine rich region was found to be very 
conserved during evolution (Figure 10). This region is located at the border between the domain b’ 
and the C-tail of the chaperone. Moreover, in the available ERp44 crystals, part of the C-tail 
(residues 332–350) is not resolved, suggesting an higher flexibility of the region116. In particular 
there are five histidine residues called here after A, A’, B, C and D. C and D are present at the 
beginning of the unstructured region of the C-tail while A and A’ are in the domain b’. In literature 
is known that histidine residues can change protonation near pH 6,5-6,0 and we previous described 
that ERp44 is a pH regulated chaperone
29
. The presence of two of the histidines in unstructured 
region reinforces the hypothesis that this region can play a fundamental role for co-factor binding to 
ERp44 (both regulators and ions). To investigate the role of the histidine rich region, a deletion 
mutant of ERp44 (ΔHis) was created by substituting residues 332-350 with a spacer (SGSG).  
 
Fig.10 Sequence alignment of the proximal part of the ERp44 C-tail. The amino acidic sequence of the histidine rich 
region and of the first part of the C-terminal tail reveals high sequence conservation in different organisms. Three 
histidine residues reside in the tail (B, C and D, highlighted here in red) and two in the domain b’ (A and A’, in light 
blue). The unstructured region in the crystal and the region deleted in the ΔHis mutant are indicated by blue and red 
brackets. 
 
Even if ERp44 ΔHis behaved similarly to the wt protein in vitro, the mutant did show evident 
phenotypes in vivo. In particular, secretion assays clearly demonstrated that:  
a) ΔHis was in part secreted and the residual retention of the mutant is due to KDEL-Rs activity; 
b) ΔHis was more efficient than wt protein in retaining Ero1α, a known partner of ERp44; 
c) Ero1α retention is pH independent;  
d) co-expression of ERp44 ΔHis and Ero1α impairs mutant secretion. 
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Thus, the deletion of histidine rich region allows ERp44 secretion unless a high affinity client is 
present. This also suggests that clients could favor RDEL motif exposure in ERp44 ΔHis like in a 
client induced retrieval mechanism. At the same time, deletion of the histidine rich region increases 
the ability of ERp44 to retain its partners (both Ero1α and Ig-µΔCH1) in a pH-independent way.  
How could a partially secreted protein (ERp44 ΔHis) be hyperactive in retaining a soluble and 
potentially secretable partner (Ero1α)? By looking at the cellular localization of ERp44 ΔHis it was 
discovered that while over-expressed ERp44 wt is present at ER-ERGIC level
70,115
, this mutant 
accumulates in more distal regions, a localization that could favor capture of clients destined to be 
retrieved. Taking in account the previous data on differential secretion of ERp44 ΔHis with and 
without its partners, the localization of the mutant was analyzed in presence of Ero1αGFP (a 
partner) or in co-expression with sGFP-RDEL (a non-partner). Clearly, the co-expression of 
Ero1αGFP, but not sGFP–RDEL, caused re-localization of ERp44 ΔHis into the ER (Figure 11). 
Thus, these data reinforce our previous hypothesis about the client induced retrieval of ERp44 
which implies that interaction with high affinity clients keep the C-tail of ERp44 in an open 
conformation, favoring the exposure of RDEL motif and the KDEL-Rs dependent retrieval of the 
entire complex (ERp44-client) to the ER. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.11 Client-induced relocalisation of ΔHis to the ER. Co-expressing Ero1α–GFP, but not sGFP–RDEL, causes the 
relocalization of ΔHis in the ER. HepG2 cells were co-transfected with Halo-tagged ERp44 ΔHis and sGFP–RDEL or 
Ero1α–GFP and then decorated with a Halo ligand (red signal). Clearly, no co-localization is detectable between sGFP–
RDEL (green) and ERp44 ΔHis (red), whereas expression of Ero1α–GFP also causes ΔHis to localize in the ER, 
yielding a reticular yellow staining (bottom right panel). 
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Considering their conservation from Homo sapiens to Caenorhabditis Elegans, histidine residues 
were replaced singularly or in combination (Figure 10). The more histidines are replaced the more 
ERp44 is secreted and, as for the deletion mutant ERp44 ΔHis, the co-expression of Ero1α alters 
their secretion in favor of retention. In line with sequence conservation during evolution, histidine 
A, B, C appear to be the most important in regulating the C-tail movements, while A’ and D seem 
to play an accessory role. Western blot analysis with anti-Ha revealed the presence of two bands in 
the histidine mutants lysates (In) and only the upper band is present in the outside medium (Sec) 
(Figure 12).  
 
 
 
 
 
 
 
 
 
Fig.12 Replacement of histidine residues causes ERp44 modification and secretion. Aliquots from lysates (In) and 
culture medium of HeLa transfectants expressing the indicated ERp44 mutants were collected and blotted with anti-HA 
antibody. Note that anti HA detects two bands in the lysates of histidine mutants (BCD and ABCD) of which only the 
upper one is present in the secreted material (pointed with a black arrow). ERp44 wt is represented as a single band in 
intracellular material (pointed with green arrow).  
 
Although ERp44 has no potential N-glycosylation sites, mutants that escaped KDEL-R dependent 
retrieval could undergo O-glycosylation in the Golgi. 
To establish if this was the case, HeLa transfectants were treated with brefeldin A (BFA), a drug 
known to induce the retrograde transport of Golgi enzymes to the ER
133
. The electrophoretic 
mobility of ERp44 wt and BCD mutant was impaired after BFA treatment while the one of ERp44 
ΔHis was not (Figure 13). Treatment of lysates with O-glycosidase restored the faster migration and 
abolished the doublet observed in the BCD intracellular material, demonstrating that ERp44 can be 
O-glycosylated before being secreted downstream the ER. In contrast, ERp44 ΔHis is not modified 
in presence of BFA indicating that either the target residue was deleted in this mutant or the 
replacement caused its inaccessibility to O-glycosyl transferases. 
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Fig.13 Secreted ERp44 is O-glycosylated. HeLa cells transfected as indicated were treated with (lanes 3, 4, 7, 10) or 
without brefeldin A (BFA) for 4 h to determine whether retrieval of Golgi enzymes to the ER caused processing of 
ERp44. Aliquots from the lysates were digested with (lanes 2, 4, 6, 9) or without O-glycosidase, resolved by gel 
electrophoresis and blots stained with anti-HA antibody.  
 
The fact that most ERp44 wt  was not modified in normal conditions implied its retrieval before the 
modification occurs. In silico prediction programs
134,135
 pointed at threonine residues 338 and 340 
as possible substrates of O-glycosylation. Both are located within the loop deleted in ΔHis, which 
would explain why this mutant is not O-glycosylated. Replacing the most conserved one, T338, 
with alanine in a mutant that was in part secreted and modified (ABCD) was sufficient to prevent 
the processing. To verify the physiological relevance of ERp44 processing, a wide panel of cells 
and tissues was screened and we find ERp44 as a double band in primary endometrial stromal cells 
obtained from healthy donors. Treatment with O-glycosidase of lysate aliquots collapsed the 
doublet into a single band, confirming that endogenous ERp44 can undergo O-glycosylation 
physiologically (Figure 14). Notably, the relative abundance of O-glycosylated ERp44 was higher 
in endometrial stromal cells in the secretory phase than in the proliferative phase
136
. Processed 
ERp44 was detected in the spent medium of secretory endometrial cells (Figure 15). 
Fig.14 Endogenous ERp44 is O-glycosylated in 
endometrial stromal cells. Lysates obtained from 
endometrial stromal cells in their proliferative (lanes 4–
5) or secretory (lanes 3, 6–7) phase were digested with 
(lanes 5, 7) or without (lanes 3, 4, 6) O-glycosidase and 
resolved by SDS page under reducing conditions. Note 
that upon digestion, the doublet visible in untreated 
samples collapses into a single higher mobility band, 
which comprises un-glycosylated and de-glycosylated 
ERp44 (green arrow). The black arrow points at the O-
glycosylated species, the main form accumulating in HeLa (lane 2) or endometrial (lane 3) cells after treatment with 
BFA. 
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Fig.15 Endogenous ERp44 is secreted by endometrial stromal cells. Aliquots from the lysates or spent media (48 h) 
corresponding to 8x10
4 
and 7x10
5
 endometrial cells in their secretory phase were immunoprecipitated (IP) with the 
monoclonal anti-ERp44 antibody, resolved under reducing conditions and stained with rabbit anti-ERp44 antibody. 
Lanes 1 and 2 show one-third of the spent medium before (Input) or after (L.O., left over) immunoprecipitation. 
The band migrating above the 50-kDa marker is BSA, which is highly abundant in fetal calf serum. Cross-linked beads 
were used as a negative control (lane 4). Endogenous ERp44 is clearly detectable in the culture medium and migrates 
with a molecular mass similar to the O-glycosylated ERp44 species present intracellularly (black arrow). 
 
Exploring partner binding by ERp44 into ESC  
Knowing that histidine mutants could be O-glycosylated in the distal ESC, these mutants 
were used as a marker of ERp44 complex formation with different partners. Thus, the binding 
before the O-glycosylation site would increase the amount of the un-glycosylated ERp44, while O-
glycosylated ERp44 should increase if the binging occurs post O-site. Over-expression of Ero1α 
and Prx4 favors the accumulation of un-modified ERp44, while Sumf1 is able to bind ERp44 also 
after sugar attachment. These observations tell us that, depending on partner affinity for ERp44 
binding site and on the surrounding environment (different pH and/or variable co-factor 
concentration), ERp44-client complexes form before or downstream the subregion where O-linked 
glycosylation takes place. The client-induced retrieval mechanism described before may allow the 
distinct and sequential localization of ERp44 interactors along the ESC (Figure 16).  
To isolate novel ERp44 molecular partners, a special tag, called Halo tag, was added to ERp44. 
Since ERp44 has a mobile C-tail that regulates partner binding and ERp44 localization, Halo tag 
was inserted between the ERp44 leader sequence and the coding one, to not influence the C-tail 
movements and ERp44 localization. HaloERp44 constructs were generated and their expression, 
activity and localization were tested in different cell lines (HeLa and HepG2). Having confirmed 
that Halo-ERp44 recapitulates most of the properties of ERp44, we are proceeding with the 
interactome study. Moreover, to follow the dynamic processes engaged in protein folding and 
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secretion, Halotag technology was used to study the behavior of protein with different fates in ESC: 
a chaperone (ERp44), an ERAD substrate (Ig-µs) and an aggregation-prone molecule (Ig-µΔCH1) 
(see Mossuto et al., 2014 for more details). Exploiting the Halo property of binding covalently 
ligands labelled with different fluorochromes, we monitor protein secretion and degradation and we 
discriminate between old and newly made proteins without using radioactive labelling. We can also 
follow the biogenesis, growth, accumulation and movements of protein aggregates in the ESC. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.16 Schematic representation of sequential client binding. The lower pH encountered by ERp44 as it proceeds along 
the early secretory pathway, favors opening of the C-tail and KDEL-R binding regardless of the presence or absence of 
high-affinity client proteins. By contrast, mutants lacking key conserved histidine residues or a loop at the border 
between the domain b’ and the C-tail bind poorly to KDEL-Rs, proceed towards the extracellular space and are O-
glycosylated. Client binding induces KDEL-R dependent retrieval of histidine mutants before (Ero1α, Prx4) or after 
(Sumf1) O-glycosylation takes place.  
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Discussion and Future issues 
Cells possess an extensive network of components to safeguard proteome integrity and 
maintain protein homeostasis, the so called cell proteostasis
137
. Mammalian cells must ensure that 
more than 10.000 different proteins fold, assemble efficiently and preserve their functionally active 
states in a wide range of environmental and metabolic conditions. This is a challenging task, 
because proteins are only marginally stable at physiological temperature and are constantly at risk 
of misfolding
137
. In addition, the concentration and subcellular localization of each individual 
protein species needs to be carefully controlled. That’s why the subdivision of the early secretory 
pathway in distinct subcellular compartment and the dynamic expression of different chaperones 
and enzymes are crucial for maintaining the cell protein factory under control. When the 
proteostasis network declines in performance, as occurs during aging, newly synthesized proteins 
are no longer able to fold efficiently and metastable proteins lose their functionally active 
conformations, particularly under conditions of cell stress. Apart from “loss of function” effects, a 
critical consequence of these proteostasis defects is the accumulation of toxic protein aggregates in 
different cell compartments, which is associated with many age-dependent neurodegenerative 
diseases and other medical disorders (for example unfolded protein diseases)
137
. One of the 
fundamental questions in cell biology is how size and activity of the different ESC compartments 
are regulated in physiological as well as in stress conditions. For instance, the secretory route is 
traversed by intense membrane fluxes whose extent and composition must be tightly regulated to 
prevent dangerous events that could induce cell death. Recent studies demonstrated that the paring 
between KDEL-Rs and specific partners is crucial for regulating retrograde and anterograde traffic 
in ESC, adapting the subcellular compartment composition and extent to cell demands 
109, 112, 113
. 
The study of ESC resident chaperones can be a good target to understand more about flux sensors 
and cell response. 
One of the known partners of KDEL-Rs is ERp44, a multifunctional chaperone of ESC, involved in 
different cell functions such as distal quality control and calcium signaling. The data I obtained 
regarding the activity and localization of this protein has proven more information about how a 
chaperone of ESC is able to cycle and bind specific clients in different sub-compartments and is 
improving our knowledge about physiological and pathological processes.  
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ERp44 regulation by the pH gradient between the ER and the Golgi 
The existence of a pH gradient between ER and Golgi complex is known from 1978 and is 
important for numerous processes like cell signaling, protein folding and trafficking and lectin 
activity 
100-103
. The discovery of ERp44 as a pH regulated chaperone adds more information about 
the importance of H
+
 concentration in regulating protein quality control and oxidative folding and in 
selective protein secretion
29
. In fact, the pH regulated opening of ERp44 C-tail determines both 
client capture and KDEL-Rs mediated retrieval and, as consequence, the activation of a signal 
cascade that alerts the ER about the incoming proteins and membrane fluxes. Owing to the fact that 
the two cysteine residues (C29 and C63) in SBS are progressively more exposed from ER to Golgi 
complex, different clients can bind proximally or distally along the secretory route. Moreover, the 
nature of these interactions can be covalent or not, also depending on the affinity of the client for 
the substrate binding site. Moreover, differences in the pH optimum for ERp44 interactions with 
partners may account for differences in the intracellular distribution of specific clients like Ero1α, 
which is also present at mitochondrial-associated ER membranes (MAM) and can regulate calcium 
signaling
126,138
. ERp44 can receive clients from, and associates with, ERGIC-53
71
, a lectin that also 
embraces glycoproteins released by the calnexin/calreticulin quality control
8
. The ERp44-ERGIC53 
tandem may thus integrate thiol-mediated and glycan-trimming-dependent ER quality control 
cycles. So ERp44 can act as a shuttle for soluble proteins that need to be in different ESC 
compartments depending on certain cellular demand and occasionally to be secreted. In line with 
the model of pH dependent retention, silencing of ERp44 causes the secretion of proteins with 
exposed reactive cysteine residues like IgM
71,139
, adiponectin
73,140
, SUMF1
119,120
, and 
peroxiredoxin4
63
. Similarly upon Golgi pH basification ERp44 partners like Ero1α, adiponectin, 
and IgM are secreted presumably because the SBS of ERp44 remains less accessible. Interestingly, 
even if its clients are secreted, ERp44 is not found in the spent medium of cells with an altered ESC 
pH gradient. This led us to think that the kinetic of tail opening is not a two-step one: probably at 
ERGIC-Golgi pH, the C-tail flips rapidly and can then be stabilized in an open conformation by 
other co-factors, cargoes or regulatory proteins. In line with this hypothesis, mutation of conserved 
histidine residues at the border between domain b’ and C-tail of ERp44 have notable consequences 
on its retention, likely decreasing the RDEL accessibility to KDEL-Rs in the ERGIC-Golgi. 
Accordingly, co-expression of clients that could bind to the SBS of ERp44 and force the C-tail in an 
open conformation and thus the RDEL exposure restored the histidine mutant retrieval (see result 
section).  
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A possible role for extracellular O-glycosylated ERp44: the endometrium and the menstrual cycle 
The study of histidine mutants also shows that ERp44 can be O-glycosylated and that this 
modification can be used as a marker of ERp44 localization and secretion. In fact, the more ERp44 
is accumulated in the distal ESC the more is abundant the O-glycosylated form of the chaperone 
and which can be also present in the spent medium. Accordingly with these observations, stromal 
endometrial primary cells secrete ERp44 in the secretory phase of the menstrual cycle
30
. In human 
beings, the menstrual cycle begins with the proliferative phase under the influence of estrogen 
levels, leading to epithelium and stroma proliferation and vasphase
141
. Analyzing different samples 
of primary endometrial stromal cells, we observed that the amount of O-glycosylated ERp44 
changes during the menstrual cycle, with a peak when the cells are in the early secretory 
phase(Figure16): this suggests that the amount of intracellular O-glycosylated ERp44 could 
correlate to cell demand for secretion. After ovulation, in fact, the endometrium starts to be 
prepared to embryo implantation: this process is remarked by progesterone secretion, gland 
transition from quiescent to secretory state and stromal cells undergo differentiation for the 
predecidualization phase
141
. Thus also suggests possible role(s) for ERp44 in intercellular dialogues 
and as a marker of menstrual cycle phases.  
 
 
 
 
 
 
 
 
 
Fig.16 Schematic quantification of O-glycosylated ERp44. The histograms show the ratio between O-glycosylated and 
not O-linked endogenous ERp44 present in lysate of endometrial stromal cells taken from patients without endometrial 
pathologies. Data represent the mean of three different samples except in the case of cells in late secretory phase. The 
more the ratio is similar to 1 the more the amount of O-glycosylated ERp44 is increased.  
 
Moreover, different genes are expressed at the blastocyst attachment to the uterus during 
decidualization process. One of them is Cox2 (cyclooxygenase derived prostaglandins 2) that seems 
to play a crucial role in embryo implantation. It acts by activating PPAR-γ (peroxisome-
proliferator-activated receptor γ) and retinoidX receptor fundamental both form embryo and 
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maternal side for the implantation
142,143
. Interestingly, PPAR-γ has been described to be an essential 
regulatory factor for the transcription activity of ERp44 in adipocyte128.  PPAR-γ has been 
implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis, and 
cancer 
144
. It acts as a master gene in metabolic regulation through stimulating insulin sensitivity, 
glucose lowering, and lipid uptake and storage in peripheral organs such as skeletal muscle, liver, 
and adipose tissue. Gene transcription is regulated by PPAR-γ in at least three mechanisms: ligand-
dependent transactivation by forming heterodimers with retinoinX receptor, ligand-dependent trans-
repression, and ligand-independent repression. It seems that PPAR-γ repressed ERp44 expression 
through the third mechanism, favoring adiponectin secretion
128
. Taking into account these data, we 
can speculate that ERp44 is a new target of transcript regulation by known transcription factors 
depending on the menstrual cycle phase and that it is expression and O-linked modification could 
be mis-modulated in certain pathologies like in diabetes type I that can let to spontaneous abortion. 
Searching for novel ERp44 partners/cargoes 
Some ERp44 clients are more effective than others in competing for SBS in the histidine mutants. 
In particular, Ero1α and Prx4 bind to ERp44 mainly before it undergoes O-glycosylation, whereas 
Sumf1 can also interact afterwards. These observations suggest that different proteins could be 
deposited sequentially in the exocytic pathway, depending on their affinity for ERp44 and on the 
pH dependency of the chaperone–client interactions. Along these lines, it is interesting that most 
ERp44 substrates and/or partners that are ER-resident enzymes (Ero1α, Prx4 and Sumf1) lack a C-
terminal KDEL like sequence and rely on protein–protein interactions for their intracellular 
localization. Thus, the amount and activity of ERp44 is likely to regulate their localization and 
activity in and between different cells
145-147
. The different localization of ERp44 itself can also be 
due to interactions with sub-compartment specific resident proteins. In order to better understand 
the physiology of all these interactions, we have tried to isolate the interactome of ERp44 using a 
novel tagging technology, the Halo tag. the Halo tag, in fact, has many different applications
148
 and 
can be used to precipitate chimeric proteins (together with their partners) in a higher amount 
compared to canonical co-immunoprecipitation.  The preliminary data on the ERp44 interactome in 
HeLa cells, as a result of 3 independent experiments, are summarized in Table1. Proteins have been 
divided for their cellular localization and activity (in yellow ESC resident proteins, in blue putative 
substrates and in orange mitochondrial proteins) and subsequently organized in functional 
subcategories (highlighted with different colors). Numerous are the proteins present both at ER-
Golgi complex and at mitochondrial level, indicating that ERp44 can not only cycle between 
proximal and distal ESC but it is also present at the mitochondrial membrane associated to ER 
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(MAM), as previously described
126,138
. Moreover, we detected a large group of proteins involved in 
redox homeostasis, suggesting that they can cooperate absolving their redox activity in specific 
compartments. As a control of the specificity of the experiments, known partners are present, like 
Ero1α, peroxiredoxin-4 and Sumf1. Analysing the isolated ERp44 partners, we noticed that  2 of 
them (Sec23A and DnaJ homolog subfamily A member 1) are able to bind zinc ions (indicated by 
*) and others binds calcium ions, indicating not only a role of ERp44 in regulating calcium 
signaling but also highlighting a possible novel role as a zinc folding protein regulator. 
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ER-Golgi complex resident interactors Putative substrates 
Ac number Name Ac number Name 
Redox related proteins P02786 Transferrin receptor protein 1 
B5MCQ5 PDIA6 - ERp5 P05556 Integrin beta-1 
Q8NBK3 Sumf1 
Q9HDC9 Adipocyte PM associated protein 
Q9H3N1 TMX1 
P07237 PDI P30086 Tubulin beta-4B chain 
E9PFN5 Glutathione S-transferase kappa 1 Mithocondrial interactors 
Q96HE7 Ero1α Redox related proteins 
P30101 ERp60 - ERp57 P30041 PRX6 
Q86UY0 ERp46 Q99497 Protein DJ-1  
P13667 PDIA4 - ERp70 - ERp72 E9PH29  Peroxiredoxin-3 
Q13162 Peroxiredoxin-4 P54886 Delta-1-pyrroline-5-carboxylate synthase  
P30040 ERp29 B4DHG0  Dihydrolipoyl dehydrogenase 
Proximal ER protein quality control P30044  Peroxiredoxin-5 
P27797 Calreticulin Energy metabolism 
P11021 BIP (GRP-78) P25705  ATP synthase subunit alpha 
B4DGP8 Calnexin O75489 NADH dehydrogenase iron-sulfur protein 3 
Vesicles transport P48047 ATP synthase subunit O 
Q86UP2  Kinectin P05141 ADP/ATP translocase 2  
Q9BVK6 emp24 O95831  Apoptosis-inducing factor 1 
P55072 Transitional ER ATPase Q9NVI7 Isoform 2 ATPase family containing protein   
Q9Y678 COPG1 D6RFM5  Succinate dehydrogenase subunit 
P53621 COPA P56381  ATP synthase subunit epsilon 
F5H365  Sec23A* P00403 Cytochrome c oxidase subunit 2  
P51153 Rab13 P38117  Electron transfer flavoprotein β 
Q00610 Clathrin heavy chain 1 Lipid metabolism 
N-glycan metabolism P40939 Trifunctional enzyme subunit alpha 
P04843 Ribophorin I P30084 Enoyl-CoA hydratase 
Q14697  Neutral alpha-glucosidase AB P00505 Aspartate aminotransferase 
Calcium binding proteins P49748 acyl-CoA dehydrogenase 
K7ELL7 Glucosidase 2 subunit beta  Protein folding 
P14625 Endoplasmin - GRP94 P31689  DnaJ homolog subfamily A member 1* 
P51571 TRAP delta F5H897  Heat shock protein 75 kDa - TRAP1 
P16615  SERCA2 Others 
Others Q15691 Mitochondrial dicarboxylate carrier  
Q92896  Golgi apparatus protein 1 Q00325  Phosphate carrier protein 
Q9NQC3 Reticulon-4 
  P50454 Serpin H1 
   
Table 1 
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ERp44 as a zinc binding protein 
Whereas the C29-based tail regulation is intrinsic to ERp44 and can be revealed in vitro, the 
histidine-dependent mechanisms are evident only in vivo as they require additional regulatory 
elements. In fact, deletion or mutation of the conserved histidine residues had only marginal effects 
in vitro 
30, indicating that additional ‘histidine-region-binding factors’ regulate ERp44 in vivo. 
Searching for protein sequences similar to the histidine rich region of ERp44 by Blastp tool (query 
sequence used: DXHXXXXHRXXHH), we found few proteins with high similarity, highlighting 
the great conservation of this specific sequence in different organisms. Indeed, it is possible to 
identify an high score of similarity between the ERp44 histidine loop and 4 different zinc binding 
proteins:  
 Solute carrier family 39 and cation channel sperm-associated protein 1 in homo sapiens; 
 Dystrophin isoform X1 in canis lupus familiaris; 
 Zinc finger protein 488 in Eptesicus fuscus.  
By analyzing the available closed 3D structure of ERp44 and keeping in mind that histidine 
residues can coordinate zinc ions, we are now investigating the role of conserved histidines in 
binding Zn
2+
 and/or other putative regulatory molecules both in vivo and in vitro. Moreover, 
comparative proteomic analysis between ERp44 wt and ΔHis mutant is ongoing and will increase 
our knowledge on novel client and regulatory proteins. 
Pathophysiological role of ERp44 and its partners: platelets activation and endothelial cells 
It is described in literature that upon activation platelets can secrete ERp44 (Holbrook et al., 2010). 
This chaperone is not the only one secreted upon platelets activation together with different PDI 
family isomerases (for example PDI, ERp57, ERp5, ERp72, ERp29), which are known to be 
present in platelets secretory granules and in the outer medium or at the outer side of the  platelets 
plasma membrane
149,150
. These PDI like proteins seem to play a role in thrombus formation and in 
integrin activation. In line with the platelets secretion, several experiments demonstrated that PDI is 
also present on the surface of endothelial cells. Thus, after vascular injury, PDI and other family 
members (like ERp5, ERp46 and ERp57) can be first secreted by endothelial cells to line the area of 
injury and then secreted from bound platelets
151,152
. Numerous studies try to dissect the role of 
secreted PDI from endothelium and platelets and, even if it is the same molecule, this chaperone is 
useful for different functions (Kim K. et al., 2013). In fact, platelets PDI is crucial for the thrombus 
growth but it is not essential for platelets adhesion, function that is supported by endothelial PDI. 
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These different roles of PDI could reflect the exit from the cell together with different co-partners 
like Ero1α, ERp46 or ERp44.The majority of the PDI like isomerases secreted by platelets and 
endothelial cells are also present in our preliminary interactome of ERp44 wt, confirming a possible 
cooperation between them depending on a specific cell demand (Table1 proteins in light yellow 
subgroup). Platelet aggregation is enhanced by serotonin (5-hydroxytryptamine), a molecule 
secreted by intestinal enterochromaffin cells into the blood. The binding of serotonin to its cognate 
receptor on platelets membrane induces a modification of N-glycan content that favor aggregation 
153
. In particular, activation of serotonin receptor initiates a G-protein dependent signaling in 
platelets, which triggers the release of pro-coagulant molecules including serotonin and other 
molecules present at the α granules levels154,155. According to these finding ERp44 can be secreted 
to favor platelets aggregation (thrombus growth) in collaboration with other PDI family members. 
As described for PDI related enzymes, also proteins belonging to the redox related QSOX family 
other redox ESC enzymes (belonging to the QSOX family) can be secreted under specific 
conditions. QSOXs are able to directly oxidize unfolded reduced peptides and proteins without 
significant collateral oxidation of PDIred
156-159
. In particular, QSOX1 is an atypical disulfide catalyst 
localized at Golgi complex and it is secreted from confluent fibroblasts. It was shown that QSOX1 
can play a role in laminin incorporation into extracellular matrix favoring cell-matrix adhesion
160
. 
It’s reasonable to hypothesize a possible interaction and extracellular communication between 
ERp44-Ero1α couple and QSOX1.  
It has been recently demonstrated that the level of expression of ERp44 are six fold higher in 
preeclampic placental cells if compared to normal controls. In pre-eclampic placentas, also the 
expression of miR-101(-3p) is decreased, highlighting a possible role of miR-101(-3p) and ERp44 
in this kind of pathologic pregnancy
161
. Moreover, over-expression of miR-101(-3p) inhibits 
trophoblast apoptosis and decreases the protein level of ERp44 in culture.  
Concluding remarks and future issues: 
It is clear, from all these new emerging data, that the complex role of ERp44 in different tissues still 
needs many effort to be fully evaluated, and that it will surely give new information both on human 
pathologies and on physiological processes. Moreover, from a molecular point of view, how C29 of 
ERp44 reacts with clients to form mixed disulfides and in which state the cysteine residues of 
clients should stay to be bound by ERp44 require further investigation.  
Many more general questions regarding protein folding in the ESC still need an answer: 
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 Does co-translational folding limit the number of folding pathways a protein can take?  
 Which folding factors remain to be identified?  
 What limits disulfide bond formation in different physiological contexts? 
 
In this context, better understanding the mechanisms of activity of ERp44 will be important: 
 Which is the status of the cysteines in ERp44 client proteins? Is the mixed disulfide introduced 
between two free thiols by an oxidase, or are the client proteins in a mixed disulfide with 
another protein and ERp44 has only to mediate reshuffle? 
 Can the histidine rich region coordinate a zinc ion? Can ERp44 act as a zinc storage in the ER-
Golgi complex? 
 How ERp44 can escape the control of KDEL-Rs being thus secreted?  
 Which is the role of secreted ERp44 in a physiological contest? Could it be a DAMP (damage-
associated protein) or an anti-inflammatory signal? 
Further experiments are ongoing to try to answer these questions. 
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To warrant the quality of the secretory proteome,
stringent control systemsoperate at the endoplasmic
reticulum (ER)-Golgi interface, preventing the release
of nonnative products. Incompletely assembled olig-
omeric proteins that are deemed correctly folded
must rely on additional quality control mechanisms
dedicated to proper assembly. Here we unveil how
ERp44 cycles between cisGolgi and ER in a pH-regu-
lated manner, patrolling assembly of disulfide-linked
oligomers such as IgM and adiponectin. At neutral,
ER-equivalent pH, the ERp44 carboxy-terminal tail
occludes the substrate-binding site. At the lower pH
of the cisGolgi, conformational rearrangements of
this peptide, likely involving protonation of ERp44’s
active cysteine, simultaneously unmask the sub-
strate binding site and RDEL motif, allowing cap-
ture of orphan secretory protein subunits and ER
retrieval via KDEL receptors. The ERp44 assembly
control cycle couples secretion fidelity and efficiency
downstream of the calnexin/calreticulin and BiP-
dependent quality control cycles.
INTRODUCTION
Protein folding in the endoplasmic reticulum (ER) is monitored by
stringent quality control mechanisms that prevent release of
immature or misfolded ER client proteins to travel further along
the secretory pathway. Notable examples include the binding-
and-release cycles of BiP, recognizing exposed hydrophobic
stretches at the surface of nonnative conformers, and of cal-
nexin/calreticulin, which exploit glucosylation status of N-linked
glycans on ER client proteins to exert quality control (Ellgaardand Helenius, 2003). ER client proteins are rich in intra- and inter-
molecular disulfide bonds that are generally essential for their
function. Numerous oxidoreductases reside in the ER to catalyze
oxidative protein folding (Ellgaard and Ruddock, 2005). Also the
process of disulfide bond formation is intimately linked to the
quality control systems that prevent nonnative conformers to
exit from the ER (Anelli and Sitia, 2008).
The same mechanisms that exert ER quality control on the
folding of subunits also monitor certain steps in their oligomeric
assembly. For instance, in the case of antibodies, BiP binds the
first constant domain (CH1) of Ig heavy chain (H) and thereby
retains it in the ER until it is displaced by the Ig light chain (L)
to assemble into H2L2 structures, called ‘‘monomers’’ in the
immunological jargon (Feige et al., 2009; Haas and Wabl, 1983;
Hendershot and Sitia, 2005). The assembly process of m2L2
monomers into IgM pentamers—(m2L2)5J—and hexamers—
(m2L2)6—is favored by ERGIC-53 (Anelli et al., 2007), which re-
sides preferentially in the ER-to-Golgi intermediate compartment
(ERGIC) (Schindler et al., 1993).
Interaction of m2L2 monomers with ERGIC-53 occurs upon
release by BiP (Anelli et al., 2007), suggesting that these assem-
blies escape from the grasp of ER quality control and travel to
more distal compartments of the early secretory pathway (Cortini
and Sitia, 2010). This notion is perhaps not so surprising, as the
m2L2 monomers, even if not polymerized, are correctly folded
and partially assembled and therefore no longer substrate to
the ER chaperoning machinery. The only sign that betrays their
unpolymerized state is the free tail-piece cysteine, which in
mature IgM polymers is disulfide linked to corresponding
cysteine residues in other m2L2 monomers (Sitia et al., 1990).
Members of the PDI family of oxidoreductases associate with
free cysteines of orphan assembly subunits and thereby facilitate
their so-called thiol-mediated retention (Fra et al., 1993; Reddy
et al., 1996; Sitia et al., 1990).
We previously identified ERp44 as a PDI family member that
covalently binds Ero1 oxidases and facilitates their intracellular
localization (Anelli et al., 2002, 2003; Otsu et al., 2006). ERp44Molecular Cell 50, 1–10, June 27, 2013 ª2013 Elsevier Inc. 1
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active site (CRFS), consistent with a dedicated role in thiol-medi-
ated retention not only of Ero1 oxidases but also of orphan sub-
units of otherwise disulfide-linked oligomers, including IgM
(Anelli et al., 2003, 2007) and adiponectin (Qiang et al., 2007;
Wang et al., 2007). Moreover, ERp44 localizes predominantly
to the ERGIC (Anelli et al., 2007; Gilchrist et al., 2006), unlike
other PDI family members, which reside in the ER (Ellgaard
and Ruddock, 2005). Still, the C-terminal RDEL motif of
ERp44 allows its capture by KDEL receptors (KDEL-R) in distal
stations of the early secretory compartment, presumably for
retrieval to the ER (Anelli et al., 2003). It is yet unclear how
ERp44 cycles between its predominant localizations in the distal
early secretory pathway and the ER, and how such cycling would
relate to thiol-mediated retention.
Here we show that the pH gradient between cisGolgi and ER
controls association of ERp44 both with its clients and with the
KDEL-R. Our results suggest a model in which the simultaneous
unmasking of the client and KDEL-R binding interfaces is facili-
tated by dislocation of the ERp44 C-terminal tail (C-tail), which
in turn likely involves protonation state of the active site cysteine
(C29) at cisGolgi-equivalent pH. As such, both ERp44 activity
and its shuttling between the ER and cisGolgi are pH regulated
to drive a quality control cycle dedicated to the surveillance of
secretory protein assembly.
RESULTS
pH-Dependent Regulation of ERp44 Activity
ERp44 associates with its client proteins via disulfide linkages to
residue C29 in the active site and noncovalent interactions with
the surrounding hydrophobic patches at the substrate-binding
site (Anelli et al., 2003; Wang et al., 2008). In the ERp44 crystal
structure (Wang et al., 2008), however, the substrate binding
site is shielded from the solvent by the C-tail that submerges
into a groove delimited by the a and b0 domains (see also
Figure 4A).
The pH gradient existing in the early secretory pathway (Fig-
ure 1A, top panel) regulates ERGIC-53 (Appenzeller-Herzog
et al., 2004), a glycoprotein transporter lectin that shares several
clients with ERp44, including IgM (Anelli et al., 2007). pH also
regulates the in vitro binding of peptides to KDEL-R (Wilson
et al., 1993), which prevent ERp44 secretion (Anelli et al.,
2003). We thus surmised that the ERp44 structure, obtained
from crystals grown at pH 7.5, most likely corresponds to an
off conformation of the protein, found in the pH-neutral ER.
Arrival into the distal, more acidic stations of the early secretory
pathway, namely ERGIC and cisGolgi, could entail exposure of
the substrate binding site (Figure 1A). We therefore assessed
pH-dependent ERp44C-tail rearrangements in vitro by 1-anilino-
naphthalene-8-sulfonate (ANS) binding fluorescence spec-
troscopy (Serve et al., 2010). Consistent with the exposure of
hydrophobic surfaces in ERp44, the ANS fluorescence peak
was blue-shifted and enhanced when the pH was lowered
from 7.5 to 6.5 (Figure 1B, top panel). This hypsochromic effect
was largely abolished for a mutant in which we had engineered a
disulfide bond between C29 and the C-tail (T369C, lower panel)
to restrict its movements (Wang et al., 2008), unless the engi-2 Molecular Cell 50, 1–10, June 27, 2013 ª2013 Elsevier Inc.neered disulfide bond was disrupted with the reducing agent
DTT (Figure 1B). We concluded that accessibility of ERp44’s
substrate binding site involves pH-dependent dislocation of
the C-tail.
Next, we monitored reactivity of the active site C29 as a func-
tion of pH and found that ERp44 boundmore polyethylene glycol
2000-modified maleimide (MalPEG) as the pH was lowered from
8.0 to 6.0 (Figure 1C), with 50% MalPEG binding at pH 6.6 (Fig-
ure 1C, right panel, red dots). MalPEG binding faithfully reported
on C29 reactivity, since its substitution with serine almost abol-
ished binding. The residual binding observed in C29S involved
residue C63 (Figure 1C, right panel, turquoise dots), as indicated
by the absence of mobility shifts in the double mutant C29S-
C63A (Figure 1C). Importantly, MalPEG binding to C29S was
not influenced by pH. This finding excludes the possibility that
the results obtained with ERp44 WT reflected pH dependence
of MalPEG reactivity (Makmura et al., 2001). The T369C mutant
did not bind MalPEG, reflecting the constitutive engagement of
C29 in a disulfide bond with C369 (Figure 1C; Wang et al.,
2008). Taken together, these results indicate that both C29 and
the surrounding hydrophobic substrate binding site become
more exposed at pH values similar to those encountered down-
stream of the ER.
C-Tail Rearrangements Determine Accessibility of the
–RDEL ER Retrieval Motif
Although the RDEL motif was not resolved in the crystal struc-
ture (Wang et al., 2008), we reasoned that its accessibility would
be limited by the adjacent domain a when the C-tail is in a closed
conformation, in turn hindering its availability to KDEL-R. Indeed,
the ‘‘tail-locked’’ T369Cmutant was secreted at levels compara-
ble to a mutant lacking the RDEL motif (DRDEL) (Figure 2,
upper panels). Insertion of a spacer peptide (FLAG) immediately
upstream of the RDEL tetrapeptide—to let it protrude from the
protein—increased retention of the T369C mutant to levels
similar to those for ERp44 WT with the FLAG insert (Figure 2
lower panels). The finding that FLAG-tagged ERp44 (whether
WT or T369C mutant) was less well retained than ‘‘FLAG-less’’
ERp44 WT may reflect that RDEL recognition by KDEL-R
depends in part on its context. Indeed, in ERp44 the sequence
upstream of RDEL is remarkably conserved in metazoans (data
not shown). In all, these data support the notion that an ‘‘open
and flexible conformation’’ of the C-tail increases accessibility
of the RDEL retrieval motif to its cognate receptors.
ERp44 Retains Clients in the Early Secretory
Compartment in a pH-Regulated Manner and Thereby
Patrols Oligomeric Assembly of Disulfide-Linked
Secretory Proteins
Having demonstrated in vitro that accessibility of the ERp44
active site is pH regulated, we set out to analyze pH dependency
of ERp44 activity in vivo. To this end, we silenced expression of
theGolgi pH regulator (GPHR) (Maeda et al., 2008), which specif-
ically raised the pH in the cisGolgi byR0.4 units (Figure 3A). In
line with our in vitro findings, neutralizing the ER-cisGolgi pH
gradient inhibited ERp44 reactivity with its partners/substrates,
as is evident from the GPHR silencing-induced decrease of
ERp44 being engaged in disulfide-linked complexes (Figure 3B).
Figure 1. ERp44 Reactivity In Vitro Is pH Dependent
(A) Model for pH-dependent ERp44 quality control cycling. At neutral, ER-equivalent pH, ERp44 is mainly in an off conformation, corresponding to the structure
resolved in crystals (Wang et al., 2008) with the C-tail closed. The lower pH in the cisGolgi provokes rearrangements of the C-tail that expose the substrate binding
site (C29 in yellow and surrounding hydrophobic stretches in white) and RDEL motif (depicted as an anchor), thus favoring client and KDEL-R binding,
respectively. Capture by the KDEL-R engenders retrograde transport to the ER, where ERp44 may release both KDEL-R and client proteins to engage in further
rounds of quality control, cycling through the early secretory pathway.
(B) pH-dependent conformational changes of ERp44. ANS fluorescence spectra were measured in the presence of recombinant ERp44 WT or the ‘‘tail-locked’’
T369C mutant in the presence or absence of DTT, at the indicated pH values. Exposure of hydrophobic surfaces correlates with increased and blue-shifted ANS
fluorescence.
(C) pH-dependent accessibility of C29 in the substrate binding site. In vitro MalPEG binding causes reduced ERp44 gel mobility and was analyzed at various
pH (U = unbound toMalPEG) to determine changes in the accessibility and reactivity of C29. The faint MalPEG-modified band in the C29Smutant is probably due
to alkylation of C63, as it is absent in the C29S-C63A double mutant. Also the T369C mutant, in which C29 is bound covalently to C369 in the tail, did not bind
MalPEG. At pH 6.6, about 50% of ERp44 WT is bound to MalPEG (see quantification on the right, red dots). Note that MalPEG binding C29S (tourquoise dots)
does not change as a function of pH. Data are represented as average of three experiments ±SEM.
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(2013), http://dx.doi.org/10.1016/j.molcel.2013.04.016Consistently, thiol-mediated retention of ERp44 client proteins
was inhibited upon GPHR silencing, as indicated by increased
secretion of overexpressed Ero1a (Figures 3C and 3F and see
Figure S2 online), adiponectin (APN, Figures 3C and 3F), and
IgM assembly intermediates (Figures 3D and 3F).
Intracellular retention of Ero1a is a task that ERp44 shares with
PDI, and overexpression of either ERp44 or PDI enhances Ero1a
retention (Anelli et al., 2003; Otsu et al., 2006) (Figure 3C and Fig-
ure S2B). GPHR silencing strongly subdued this enhanced Ero1a
retention when ERp44 was overexpressed, but much less so in
the case of PDI overexpression (Figure 3C). Secretion of proteins
that are not ERp44 clients, like a1-antitrypsin (a1AT) or a solubleGFP engineered for entry into the secretory pathway (sGFP), was
also unaffected by raising the cisGolgi pH (Figures 3E and 3F).
We concluded that ERp44-mediated retention in particular relies
on the ER-cisGolgi pH gradient. Accordingly, retention of unas-
sembled monomeric Ig-m chains, which is mediated not by
ERp44 but by the chaperone BiP, was pH insensitive (Figures
3D and 3F). Only when the CH1 domain, which is important for
BiP binding (Haas and Wabl, 1983; Lee et al., 1999), is deleted
(mDCH1) or engaged in interactions with Ig-L chains (as in m2l2
complexes) does ERp44 become the primary retainer of the
Ig-m chains, and hence their retention becomes pH dependent
(Figures 3D and 3F).Molecular Cell 50, 1–10, June 27, 2013 ª2013 Elsevier Inc. 3
Figure 2. Rearrangements of the C-Tail
Expose the –RDEL Motif
HeLa transfectants were pulsed with radiolabeled
amino acids and chased in cold medium. At
the indicated times, aliquots from the lysates
(Intracellular) and supernatants (Secretion) were
immunoprecipitated and analyzed by gel electro-
phoresis. Radiographs of a representative experi-
ment are shown on the left; arrows indicate
bands corresponding to overexpressed ERp44;
the higher molecular weight of secreted ERp44
reflects posttranslational modifications (see also
Anelli et al., 2003, 2007). Intracellular ERp44 levels
were quantified from four to six experiments. Mean
values and SEM are depicted in the graph shown
on the right. Statistical significance was calculated
by ANOVA one-way with Bonferroni’s post test and indicated by brackets (T369C-FLAG-WT-FLAG, p = 0,041; T369C-T369C-FLAG, p = 0,006). In T369C,
formation of a C29-C369 intrachain disulfide limits C-tail movements, likely impeding RDEL binding to its receptors. Inserting a spacer peptide FLAG tag
upstream RDEL partially restores retrieval. The partial secretion of ERp44 WT upon insertion of a FLAG tag could depend on the acidity of the inserted peptide
and/or its binding to the substrate binding site and hence reduced reactivity/accessibility of the RDEL tetrapeptide.
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(2013), http://dx.doi.org/10.1016/j.molcel.2013.04.016Retention of sGFP-RDEL was pH insensitive (Figure 3E), as
expected for a protein that lacks free cysteines and hence is
not an ERp44 client. This finding implies at the same time that
KDEL-R function, which is crucial for sGFP-RDEL retention, is
not corrupted despite the rise in cisGolgi pH. Likewise, ERp44
was retrieved by KDEL-R despite GPHR silencing (Figure S2B),
whereas this treatment allowed secretion of ERp44 client pro-
teins (Figure 3F). Perhaps a partial C-tail opening in distal sta-
tions of the secretory pathway, which are less affected by
GPHR silencing (Maeda et al., 2008), is sufficient for KDEL-R
recognition but not for client binding.
The Reactive Site Cysteine 29 Is a Key Element in pH
Regulation of C-Tail Opening and ERp44 Activity
Considering that the conformational changes that facilitate C-tail
dislocation are induced by lowering the pH as ERp44 travels to
the cisGolgi, we surmised that a protonation event may lie at
the basis of the switch between the on and off conformations
of ERp44. To explore this notion, we analyzed the crystal struc-
ture of ERp44with the C-tail in the closed conformation using the
program PROPKA3, a state-of-the-art semiempirical method
that evaluates pKa values of ionizable residues starting from pro-
tein structures (Li et al., 2005; Olsson, 2011; Olsson et al., 2011).
The most striking feature that emerged from the PROPKA3 anal-
ysis was the downward shift of the pKa of C29. Its predicted
value of 7.7 units (Table 1) is significantly lower than the refer-
ence value for free cysteine in solution (9.0). This shift is mainly
ascribed to the propensity of the neighboring side-chain hy-
droxyls of S32 and T369 and the main-chain amides of residues
F31, S32, and T369 (Table 1 and Figure 4B) to form hydrogen
bonds with C29 when in the thiolate form. Likewise, electrostatic
interactions with the R98 side chain stabilize the thiolate form of
C29 (Table 1). Based on this pKa value, a significant percentage
of C29 would be in the thiolate form (41%) at pH 7.5 (Figure 4B
and Table 1). Conversely, only 6.5% of C29 was predicted to
be in the thiolate form at pH 6.5 (Table 1).
When we removed the b16 strand from the crystal structure
in silico, simulating an ‘‘open’’ C-tail conformation of ERp44,
the calculated pKa of C29 raised to 7.8 (Table 1). The effect4 Molecular Cell 50, 1–10, June 27, 2013 ª2013 Elsevier Inc.was even more pronounced in sample structures at the end of
molecular dynamics simulations of this Db16model. As a conse-
quence of a greater solvent exposure, loss of hydrogen bonding
to T369, and an increased distance to the side chains of both S32
and R98, C29 had a calculated pKa of 8.7, implying that only a
small percentage (6%) of C29 is in the thiolate form at pH 7.5
(Table 1 and Figure 4C).
Based on our in silico analyses, we mutated the residues pre-
dicted to affect the pKa of C29 in ERp44. Altering the side-chain
groups such that they could no longer contribute to the stabiliza-
tion of the thiolate form of C29 through hydrogen bonds or elec-
trostatic interactions (S32A, R98Q, or T369A) indeed rendered
ERp44 constitutively accessible to MalPEG and abolished the
pH sensitivity of the reaction (Figure 4D). Deletion of strand
b16 gave similar results (Figure 4D), supporting the notion that
the S32A, R98Q, and T369A substitutions similarly led ERp44
to adopt the ‘‘open’’ C-tail conformation.
We then analyzed whether the enhanced accessibility of the
ERp44active site in the variousmutants correlatedwith its affinity
toward substrates. In surface plasmon resonance (SPR) assays
(Masui et al., 2011), ERp44 WT showed a pH-dependent reac-
tivity toward Ero1a, having a higher affinity for its partner at
pH 6.5 than at pH 7.5 (Figure 4E). All the mutations that resulted
in constitutive and pH-independent MalPEG binding of ERp44
made it also less pH dependent in SPR assays and increased
its affinity for Ero1a (Figure 4E). The effect was weakest for the
R98Q mutant, in agreement with the modest contribution of
this arginine in stabilizing the thiolate form of C29 (Figure 4C).
In summary, our data indicate that C29, S32, R98, and T369
are components of the ERp44 pH-sensing mechanisms. The
predicted pKa of C29 approaches neutral pH due to the interac-
tion of its side chain with the surrounding residues, suggesting
that its protonation, when ERp44 encounters the lower pH in
the cisGolgi, is a key event for C-tail opening, and, hence, expo-
sure of the substrate binding site.
pH Sensing by ERp44 In Vivo
We then further substantiated our findings on the mechanisms
mediating ERp44 pH sensitivity by analyzing the phenotype of
Figure 3. ERp44 Activity In Vivo Depends on
the pH Gradient between ER and cisGolgi
(A) GPHR silencing ablates cisGolgi acidification.
The pH in the cisGolgi wasmeasured by organelle-
targeted GPP130-pHluorins (Miesenbo¨ck et al.,
1998), in HeLa cells expressing GPHR-specific or
irrelevant siRNA, as indicated. Histograms display
mean pH values ± SEM. *p = 0.001.
(B) GPHR silencing inhibits the accumulation of
covalent complexes at steady state. Lysates of
HeLa cells exposed to GPHR-specific (+) or irrel-
evant () siRNA were resolved under nonreducing
(NR) or reducing (R) conditions in a 3%–8%
acrylamide precasted gradient gel or in a 10%
acrylamide gel, respectively. Nitrocellulose was
decorated with monoclonal anti-ERp44 antibodies
(36C9). As calculated by densitometric quantifi-
cations of two similar gels, the amount of ERp44
engaged in covalent complexes decreases by
40% after GPHRi.
(C and D) GPHR silencing specifically inhibits
retention of ERp44 clients. Aliquots from lysates
(Intracellular) and culture media (Secretion) were
collected from HeLa transfectants expressing
Ero1a (C, upper and lower panels), adiponectin
(APN; C, midpanel), or Ig-m, mDCH1, Ig-l (D), and
subjected (+) or not () to GPHRi. ERp44 or PDI
was coexpressed with Ero1a or adiponectin as
indicated (C). (See also Figure S2.) Samples were
analyzed under reducing or nonreducing condi-
tions (C and D, respectively) and analyzed by
immunoblotting with relevant antibodies. Bands
corresponding to m, mDCH1, m2l2, and mDCH12 are
indicated by arrows in (C).
(E) GPHR silencing does not affect transport of
non-ERp44 clients, such as a1-AT or secretory
green fluorescent protein extended a C-terminal
RDEL peptide (sGFP-RDEL) or not (sGFP). Ali-
quots of cell lysates (Intracellular) and superna-
tants (Secretion) were collected and analyzed
under reducing conditions.
(F) To compare the effects of GPHR silencing on
the transport of the indicated proteins, the levels of
intracellular and secreted proteins were quantified
by densitometric analyses of four to ten experi-
ments like the ones shown in (C)–(E) and Fig-
ure S2B. The percentage of secretion was then
calculated relative to the intracellular pools. Histograms show the mean fold of induction upon GPHR silencing relative to cells treated with irrelevant siRNA ±
SEM. Statistical significancewas calculated using the paired Student’s t test for parametric data. Ero1a, p = 0.038; Ero1a + ERp44WT, p = 0.001; APN, p = 0.033;
APN + ERp44 WT, p = 0.012; m2l2, p = 0.004; mDCH1, p = 0.040.
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(2013), http://dx.doi.org/10.1016/j.molcel.2013.04.016the abovemutants in vivo. In linewith the in vitro results, mutation
of the residues expected to affect the pKa of C29 (S32, R98, and
T369) dramatically increased the tendency of ERp44 to form
covalent complexes with client and partner proteins, reaching
levels comparable to a mutant lacking the whole b16 strand
(see Figure 5A and Figure S3A). This was particularly evident
when anti-HA antibodies were used to selectively analyze the
behavior of the overexpressed transgenes (Figure S3A). We
concluded that the S32A, R98Q, and T369Amutations increased
the accessibility of C29 also in vivo, likely reflecting a more
‘‘open’’ conformationof theC-tail. In further support of ourmodel,
pHsensitivity ofERp44activitywas lost in all thesemutants, since
the fraction of molecules covalently bound to client and partnerproteins did not decrease uponGPHRsilencing in thesemutants,
as it did instead in ERp44 WT (Figure 5A). In addition, the activity
of thesemutants in retaining adiponectin was no longer sensitive
to basification of the cisGolgi (Figure 5B and Figure S3B). Similar
results were obtained also on Ero1a secretion (data not shown).
Therefore, pH sensitivity is severely reduced when the critical
residues S32, R98, and T369 are mutated and, consequently,
the predicted C29 pKa is raised over neutral values.
DISCUSSION
The pH gradient between ER and Golgi may serve multiple
roles in the cell, such as calibrating activity of lectins and GolgiMolecular Cell 50, 1–10, June 27, 2013 ª2013 Elsevier Inc. 5
Table 1. Modulation of the pKa of C29 in ERp44 as Predicted by PROPKA3
Structure pKa
Percentage
Thiolate at
pH 7.5
Percentage
Thiolate at
pH 6.5 Desolvation
Side-Chain HB Backbone HB Coulombic
S32 T369 F31 S32 T369 R30 R98 D64 K77
WT ERp44 Closed 7.66 40.9 6.5 2.09 0.85 0.85 0.46 0.83 0.33  0.12 0.01 
Db16 7.84 31.4 4.4 1.06 0.85  0.46 0.83   0.09  
Db16 MD Snapshot 8.7 5.9 0.6 0.71 0.33  0.04 0.57  0.03 0.02  0.02
Deconvolution of the contribution of C29 neighboring residues to the pKa shifts in ERp44. The pKa of residue C29 of the different ERp44 models was
predicted using PROPKA3. The percentage of thiolate at a given pH was calculated using the equation%[thiolate] = KA/([H
+]+KA). The values reported
in the Desolvation, Side-Chain HB, Backbone HB, and Coulombic columns are the pKa shifts from the model value in water (9.0) due to the different
interactions listed. HB, hydrogen bond.
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(2013), http://dx.doi.org/10.1016/j.molcel.2013.04.016glycan-modifying enzymes (Paroutis et al., 2004). We have
shown here that the pH gradient is exploited also for regulating
quality control and secretion of a selection of key proteins.
pH-regulated opening of ERp44’s tail determines both client
capture and KDEL-R-mediated retrieval. Thus, ERp44 governs
a pH-regulated protein quality control cycle shuttling between
cisGolgi, where ERp44 engages its clients, and the ER, where
they must be released and where ERp44’s C-tail presumably
closes to occlude the client binding active site. Our in vitro
MalPEG binding studies reveal a midpoint transition for ERp44
at a pH of approximately 6.6, a value similar to that found in
the cisGolgi (Figure 3A). In all likelihood, however, additional
mechanisms contribute to the regulation of ERp44 activity in
living cells. For instance, interactions with KDEL-R may prevent
closing of the C-tail and perhaps provide interaction with addi-
tional proteins.
Owing to the fact that the opening of the C-tail is pH depen-
dent, the substrate binding site of ERp44 becomes more
accessible progressively from ER to cisGolgi. Client proteins
may thus engage ERp44 more proximally or distally along the
early secretory pathway, according to their affinity toward the
substrate binding site at a given pH. Differences in the pH
optimum for ERp44 association may thus account for differ-
ences in the intracellular distribution of Ero1a, which is enriched
at mitochondrial-associated ER membranes (Anelli et al., 2012;
Simmen et al., 2010) and resides overall more distally in the
early secretory pathway, as compared to another ERp44 client,
SUMF1, which localizes to the more proximal stations (Fraldi
et al., 2008).
In the crystal structure of ERp44, the active site C29 is buried
at the interface between domain a and the C-tail (Wang et al.,
2008). The environment in which C29 resides induces a down-
ward pKa shift of this residue toward neutral values, de facto sta-
bilizing the thiolate form of the amino acid. The negative charge
of the deprotonated C29 restrains the C-tail movements via
hydrogen bonds to S32 and T369 and electrostatic interactions
with R98, which also interacts with the tail backbone. Upon entry
of ERp44 into the cisGolgi compartment, C29 protonation likely
occurs. This event, in turn, weakens C29 interactions with sur-
rounding residues, as a cysteine with a side-chain thiol is less
effective in forming the same hydrogen-bonding and long-range
Coulombic interactions that the thiolate can maintain. How C29
of ERp44 reacts with clients to form mixed disulfides and
whether ERp44 can act alone or requires assistance for this pro-
cess deserves further investigation.6 Molecular Cell 50, 1–10, June 27, 2013 ª2013 Elsevier Inc.In line with our model, silencing of ERp44 causes more abun-
dant secretion of many proteins with one or more exposed reac-
tive cysteine, including Ig-m (Anelli et al., 2007; Ronzoni et al.,
2010), adiponectin (Wang et al., 2007; Qiang et al., 2007),
SUMF1 (Fraldi et al., 2008; Mariappan et al., 2008), and peroxir-
edoxin 4 (T. Kakihana, K. Araki, S.V., I. Shun-ichiro, M.C., C.F., T.
Natsume, R.S., and K. Nagata, unpublished data). Similarly,
upon neutralization of the Golgi pH, ERp44 substrates like
Ero1a, adiponectin, and IgM subunits are secreted more abun-
dantly, presumably because the active site of ERp44 remains
largely inaccessible. However, ERp44 itself is efficiently retained
intracellularly. This observation suggests that ERp44 could
partially open the C-tail, exposing its RDEL, and interact with
KDEL receptors without binding client proteins through an
as-yet-unknown mechanism.
ERp44 receives substrates from, and associates with, ERGIC-
53 (Anelli et al., 2007), a lectin that also embraces glycoproteins
released by the calnexin/calreticulin quality control (Ellgaard and
Helenius, 2003). The ERp44-ERGIC-53 tandem may thus inte-
grate thiol-mediated and glycan-trimming-dependent ER quality
control cycles. Similarly, we have shown that upon displacement
by Ig-L, BiP no longer warrants retention of orphan Ig-H chains
but leaves this role to ERp44 instead. ERp44 indeed is strongly
upregulated in the course of B cell differentiation (van Anken
et al., 2003; Anelli et al., 2007) to help avoid release of incom-
pletely assembled IgM, which would jeopardize the efficiency
of the humoral immune response. The ERp44 assembly control
cycle thus embodies the last-resort quality control mechanism
to prevent the untimely exit from the early secretory compart-
ment of orphan subunits of otherwise disulfide-linked oligomeric
secretory proteins.
EXPERIMENTAL PROCEDURES
Constructs
The cDNA encoding human ERp44 without the signal sequence was amplified
by PCR and cloned into pET28 vector (from Novagen) at NheI and XhoI sites.
The recombinant form of ERp44, which was overproduced in E. coli, lacks
the RDEL motif at the C terminus. Vectors for expression of HA-ERp44
in mammalian cells were previously described (Anelli et al., 2002). Mutants
were obtained by polymerase chain reaction (PCR) or site-directed mutagen-
esis (SDM) (Table S1). Human ERp44-FLAG-RDEL was a kind gift of Professor
K. Nagata (Kyoto-Sangyo University). The construct encoding the GPP130
pHluorin probe was a kind gift of Dr. J.E. Rothman (Center for High Throughput
Cell Biology, Yale University). Plasmids encoding a1AT and adiponectin were
kindly provided byDrs. R.N. Sifers (Baylor College ofMedicine) and P. Scherer,
respectively. pcDNA3.1-sGFP was obtained by appending the signal peptide
Figure 4. The Environment around C29 of ERp44 Modulates its pH-Dependent Reactivity at Physiological Values
(A) Overall structure of ERp44 (Wang et al., 2008), presented in two views related by a 90 rotation around the horizontal axis. The polypeptide folds into three
thioredoxin-like domains (a, b, and b0); b strands are shown as arrows and a helices as ribbons. The C-terminal tail is colored in red, and strands b3 and b16 are
colored blue and magenta, respectively. In the ERp44 crystal structure, residues of the b3 strand in domain a establish noncovalent interactions with the b16
strand in the C-tail, acting as a ‘‘molecular glue’’ that keeps the C-tail in the closed conformation.
(B) The panel shows a closer view of the active site C29, at the N-terminal portion of helix a2, highlighting interactions between C29 and neighboring residues
shown as a stickmodels. Hydrogen bonds between polar atoms are shown as dashed lines. The positively charged guanidinium group in the side chain of residue
R98 is 7.3 A˚ from the Sg of C29.
(C) Two-dimensional diagrams showing the effect of the different interaction between C29 and amino acid residues on the thiol pKa in the crystal structure of
ERp44 (top left panel) and in a representative snapshot from molecular dynamics simulations of the Db16 mutant (bottom right panel). The arrows represent
interactions that decrease the pKa of C29, and their thickness is proportional to themagnitude of the reduction of C29 pKa by each residue shown (see also Table
1). The structural rearrangements following b16 removal greatly reduce the effect of the polar interactions on the thiol acidity. Red arrows indicate the interactions
between side chains of each residue with C29 (which we could abolish through mutagenesis), while black arrows indicate interactions of C29 with the protein
backbone.
(D) Increased accessibility of C29 in mutants with lower tendency to thiolate formation. The indicated mutants were reacted with MalPEG at different pH and
resolved electrophoretically as described in Figure 1C. All the mutants show increased and pH-independent MalPEG reactivity.
(E) pH-dependent binding of ERp44to Ero1a. The KD of association between recombinant Ero1a andWT or mutant ERp44 was determined by SPR at pH 6.5 and
pH 7.5, as indicated. Histograms display the mean of at least four independent experiments ± SEM.
Molecular Cell
The ERp44-Mediated Assembly Control Cycle
Molecular Cell 50, 1–10, June 27, 2013 ª2013 Elsevier Inc. 7
Please cite this article in press as: Vavassori et al., A pH-Regulated Quality Control Cycle for Surveillance of Secretory Protein Assembly, Molecular Cell
(2013), http://dx.doi.org/10.1016/j.molcel.2013.04.016
Figure 5. In Vivo Analysis of pH Sensor
Mutants
(A) HeLa transfectants expressing the indicated
ERp44 mutants were exposed to GPHR-specific
(+) or irrelevant () oligonucleotides as described
in Figure 3. Aliquots were resolved under nonre-
ducing conditions and decorated with anti-ERp44
antibodies (36C9) that recognize also endogenous
ERp44 (see also Figure S3A). Sensitivity to pH was
calculated according to the formula (complexed
ERp44/monomeric ERp44 under GPHRi) / (com-
plexed ERp44/monomeric ERp44 under control
conditions) * 100.
(B) HeLa transfectants expressing the indicated
ERp44 mutants and adiponectin under GPHRi or
control conditions were washed and cultured for
4 hr in fresh medium as also described in Fig-
ure S2. Aliquots of the lysates (Intracellular) and
supernatants (Secretion) were resolved under
reducing conditions and decorated with anti-adi-
ponectin (APN) or anti-HA antibodies, which rec-
ognizes only transfected ERp44. One out of three
independent experiments is shown for ERp44 WT
and mutant Db16. Similar experiments were per-
formed with other mutants (see also Figure S3).
The graph shows the pH sensitivity of adiponectin
retention [(secreted APN / intracellular APN under
GPHRi) / (secreted APN / intracellular APN under control conditions) * 100 relative to the value obtained with ERp44 WT]. Data are represented as average of
greater than or equal to three experiments ± SEM, and statistical significance was calculated using the Student’s t test for parametric data. S32A, p = 0.041;
T369A, p = 0.052.
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Plasmids encoding WT and mutated secretory Ig-m chains (ms and mDCH1)
were described in detail previously (Cenci et al., 2006; Mattioli et al., 2006).
Biochemical Techniques
The purification of wild-type and mutant ERp44 and Ero1a was performed as
described (Inaba et al., 2010). The association and dissociation rate constants
(kON or kOFF) for the direct binding of ERp44 to immobilized Ero1a were deter-
mined by SPRmeasurements on a BIACORE2000 system (GE, Healthcare), in
the presence of 1 mM GSH and 0.25 mM GSSG as described (Inaba et al.,
2010). Experiments were replicated at least three times. Hyperactive Ero1a
(with cysteines 104, 131, and 166 replaced by Ala) was used in SPR assays
to limit variations caused by the autoregulatory mechanisms controlling
Ero1a activity (Inaba et al., 2010). ANS fluorescence spectra were recorded
in 1 cm cuvettes on a Hitachi F-4500 spectrofluorometer. ERp44 and mutants
(5 mM)weremixedwith 100 mMANS in 20mMTris-HCl (pH 7.5) orMES (pH 6.5)
containing 150mMNaCl with or without 10mMDTT and incubated at 293 K for
10 min.
Pulse-Chase, Immunoprecipitation, Western Blotting, and
Densitometric Quantification
Cells were starved for 5 min in cysteine and methionine-free DMEM (GIBCO,
Invitrogen), pulsed for 10 min with (35S) cysteine and methionine (Easy Tag,
Perkin-Elmer), washed twice, and chased for the indicated periods in complete
medium. Cell lysates and supernatants were immunoprecipitated with anti-HA
or anti-FLAG antibodies and resolved by SDS-PAGE. Fluorograms or western
blot images were acquired with the Chemidoc-it Imaging System (UVP,
Upland, CA) or with FLA-900 Starion (Fujifilm Life Science, USA) and quantified
with Image Quant 5.2 as described (Anelli et al., 2007).
Cell Culture and Reagents
Tissue culture, transfection, and silencing were performed as described previ-
ously (Anelli et al., 2007). Fetal calf serum and cell culture medium were from
GIBCO, Invitrogen. Unless otherwise indicated, chemicals were from Sigma.
Polyclonal anti-mouse m and anti-ERp44 (B68) antibodies were purchased8 Molecular Cell 50, 1–10, June 27, 2013 ª2013 Elsevier Inc.from PRIMM srl (Milano, Italy). Rabbit polyclonal anti-adiponectin antibody
was a kind gift of Dr. P. Scherer (University of Texas Southwestern Medical
Center). Monoclonal anti-GFP (clones 7.1 and 13.1) was purchased from
Roche (USA) and polyclonal anti-a1 antitrypsin (NCL A1Ap) from Novocastra.
Monoclonal anti-ERp44 antibody (36C9) was previously described (Anelli
et al., 2007). Goat anti-mouse m and l were from Southern Biotechnology
Associates, Inc. Goat anti-mouse Ig and anti-rabbit Ig horse-radish peroxidase
(HRP) were from Jackson ImmunoResearch Laboratories, Inc. Mouse mono-
clonal antibodies specific for Myc (9E10), HA (12CA5), and FLAG (M2) were
immobilized by crosslinking to protein G and protein A beads, respectively.
HRP rabbit anti-mouse IgG (H+L) was from Dako Cytomation (Glostrup, CO).
Maleimidyl PEG-2K Modification of rERp44 Cys29
Each ERp44 derivative (5 mM) was incubated on ice for 30 min in various pH
buffers containing 100 mM sodium phosphate and 150 mM NaCl, followed
by incubation withmaleimidyl PEG2K (300 mM) for 10min at room temperature.
The reaction was stopped by the addition of 5% trichloroacetic acid, and the
protein pellet was washed with acetone and dissolved in buffer containing
50 mM Tris-HCl (pH 7.0) and 1% SDS before loading onto a reducing SDS
gel (10%).
Measurement of Golgi pH by pHluorin Probes
HeLa cells expressing pME-Zeo-GPP130-pHluorin (Miesenbo¨ck et al., 1998)
were cultured on glass-bottomed dishes and analyzed under a TCS SP2 Laser
Scanning Confocal (Leica Confocal) equipped with an LD laser 405 (405 nm)
and a multiline Ar laser (457, 488, and 515 nm) at room temperature. Data
acquisition and analysis of intensity ratios (405 nm; 457 nm) were performed
as described (Miesenbo¨ck et al., 1998). At least 120 regions of interest were
analyzed by fluorescence microscopy. Statistical significance was calculated,
comparing between conditions indicated by brackets using the two-tailed
Student’s t test.
RNAi
Oligonucleotides for RNA interference (Silencer Select predesigned siRNA
products) were purchased from Ambion (siRNA ID #s56768). A final
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amine RNAi MAX was from Invitrogen (Carlsbad, USA) and used for silencing
in HeLa cells, according to the suppliers’ instructions.
In Silico Calculations
We used the PROPKA 3.0 software (http://propka.ki.ku.dk) to predict the pKa
value of ERp44 C29 and the role of surrounding amino acids starting from the
crystal structure of the entire molecule (Wang et al., 2008; PDB ID code 2R2J)
and from in silico models of the Db16 mutant. A description of the molecular
dynamics simulations is presented in the Supplemental Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at http://dx.doi.org/10.1016/j.molcel.2013.04.016.
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Supplemental Figure 1 (S1): Schematic representation of ERp44 mutants used in this study 
and related to all main text figures.  
The three thioredoxin-like domains a, b, and b' are depicted as white rectangles. The C-tail is 
shown in grey. The FLAG is boxed in light grey. The C-terminal RDEL retention motif is 
indicated. The black square at N-terminus represents the HA tag, placed immediately 
downstream of the signal sequence. All constructs expressed in E. coli that were used in in 
vitro studies lack the tag, the N-terminal hydrophobic signal sequence and the C-terminal –
RDEL motif. The latter is not resolved in the published crystal structure (PDB code: 2R2J, 
Wang et al., 2008) suggesting its high flexibility. 
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Black circles denote residues that were modified to the indicated residues by site directed 
mutagenesis. The coding sequence was severed at the indicated residues in deletion mutants 
(not in scale).  
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Supplemental Figure 2 (S2): The pH gradient along the early secretory compartment 
specifically regulates ERp44-mediated protein quality control (see also Figure 3). 
A) Scheme of the transfection and silencing experiments shown in panel B and Fig. 3B-E. 
HeLa cells were silenced with specific or control oligonucleotides 72 and 24 h before 
analysis. Transfections were performed 48 h before analysis. Efficiency of GPHR silencing 
routinely exceeded 75%, as determined by mRNA quantification (not shown).  
B) ERp44- but not PDI-mediated Ero1 retention is pH sensitive. HeLa transfectants 
expressing Ero1 alone or in conjunction with ERp44 or PDI were silenced with GPHR-
specific or irrelevant siRNA. Lysates (Intracellular) and culture media (Secretion) were 
analyzed as in Fig. 3. The arrow points at over-expressed HA-tagged ERp44. Upper right 
panels for Ero1 secretion are identical to those in Fig. 3B. The slight increase in Ero1 
secretion in PDI overexpressing cells (lane 8 of lower panel in part B of the Figure) likely 
reflects a residual role of ERp44 in Ero1 retention (Otsu et al., 2006).  
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Supplemental Figure 3 (S3), related to figure 5: In vivo analysis of pH sensor mutants. 
A) Aliquots of HeLa trasfectants expressing the indicated mutants were resolved under non 
reducing (NR) and reducing (R) conditions and decorated with anti HA antibody. Arrows 
indicate over-expressed monomeric ERp44. The * denotes a background band cross-reacting 
with our antibodies.  
B) HeLa trasfectants expressing the indicated ERp44 mutants and adiponectin under GPHRi 
or control conditions were washed and cultured for 4 hours in fresh medium (see Fig. S2). 
Aliquots of the lysates (Intracellular) and culture media (Secretion) were resolved under 
reducing conditions and decorated with anti-adiponectin (APN), anti-HA or anti-ERp44 
(36C9) antibodies, as indicated. Representative experiments are shown for different ERp44 
mutants (S32A, R98Q, T369A, T369C, Δβ16). 
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Supplemental Experimental Procedures and Supplemental References 
Molecular dynamics simulations  
The X-ray structure of ERp44 (PDB code 2R2J) was used to prepare the starting 
configuration for molecular dynamics (MD) simulations. The ∆16 structure was generated 
by deleting the coordinates of the Glu365-Arg372 segment. The missing loop in the a domain 
(Phe50-Glu53) was modelled with the ModLoop server (Fiser et al., 2000). The resulting 
structure was immersed in a cubic box (~ 97 x 97 x 97 Å3) of ~ 29,000 TIP3P water 
molecules and 13 Na+ counterions. Simulations and subsequent analyses were performed 
with GROMACS 3.3.3., using the ff-amber99sb porting (Sorin and Pande, 2005) of the 
AMBER parm99SB parameter set (Hornak et al., 2006). Periodic boundary conditions were 
imposed. The equations of motion were integrated using the leap-frog method with a 1-fs 
time step. The Berendsen algorithm was employed for temperature (T=300 K) and pressure 
(p=1 bar) regulation, with coupling constants of 0.1 ps. Bonds to hydrogen atoms were frozen 
with the LINCS method for the protein and the ligand, while SETTLE was used for water 
molecules. The Particle Mesh Method was used to calculate electrostatic interactions, with a 
11-Å cutoff for the direct space sums, a 1.0-Å FFT grid spacing and a 6-order interpolation 
polynomial for the reciprocal space sums. For van der Waals interactions, a switching 
function was used with a double 9-10 Å cut-off. Long-range corrections to the dispersion 
energy were also included (Shirts et al., 2007). The system was first minimized with 2000 
steps of steepest descent. Harmonic positional restraints (with a force constant of ~ 12 
kcal/mol/ Å2) were then imposed onto the protein heavy atoms and gradually turned off in 
400 ps, while the temperature was increased from 200 to 300 K. The system was then 
simulated for 5 ns. To assess the reproducibility of the results, two trajectories were generated 
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for the wild type protein following the same protocol. The ∆16 protein simulation was 
prolonged to 10 ns. 
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PCR, polymerase chain reaction) employed to generate ERp44 mutants used in all main text 
figures. 
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Progressive quality control of secretory proteins in the early
secretory compartment by ERp44
Sara Sannino1,2, Tiziana Anelli1,3, Margherita Cortini1,*, Shoji Masui4, Massimo Degano1,3, Claudio Fagioli1,3,
Kenji Inaba4 and Roberto Sitia1,3,`
ABSTRACT
ERp44 is a pH-regulated chaperone of the secretory pathway. In the
acidic milieu of the Golgi, its C-terminal tail changes conformation,
simultaneously exposing the substrate-binding site for cargo
capture and the RDEL motif for ER retrieval through interactions
with cognate receptors. Protonation of cysteine 29 in the active site
allows tail movements in vitro and in vivo. Here, we show that
conserved histidine residues in the C-terminal tail also regulate
ERp44 in vivo. Mutants lacking these histidine residues retain
substrates more efficiently. Surprisingly, they are also O-
glycosylated and partially secreted. Co-expression of client
proteins prevents secretion of the histidine mutants, forcing tail
opening and RDEL accessibility. Client-induced RDEL exposure
allows retrieval of proteins from distinct stations along the secretory
pathway, as indicated by the changes in O-glycosylation patterns
upon overexpression of different partners. The ensuing gradients
might help to optimize folding and assembly of different cargoes.
Endogenous ERp44 is O-glycosylated and secreted by human
primary endometrial cells, suggesting possible pathophysiological
roles of these processes.
KEY WORDS: ERp44, Golgi, O-glycosylation, Endoplasmic
reticulum, Protein quality control, Protein secretion
INTRODUCTION
ERp44 is a multifunctional chaperone of the PDI-family that
regulates Ca2+ signaling, redox homeostasis and thiol-dependent
protein quality control at the endoplasmic reticulum (ER)–Golgi
interface (Anelli et al., 2012; Cortini and Sitia, 2010). ERp44 is
key for the retrieval of orphan subunits of disulfide-linked
oligomers, like IgM and adiponectin (Anelli et al., 2003; Anelli
et al., 2007; Qiang et al., 2007; Wang et al., 2007) and for the
intracellular localization of Ero1 oxidases, Sumf1 and
peroxiredoxin 4 (Prx4) (Fraldi et al., 2008; Kakihana et al.,
2013; Otsu et al., 2006). It associates with its client proteins
covalently through cysteine 29 (C29) and non-covalently, likely
through the surrounding hydrophobic patches in the substrate-
binding site (SBS). In the available crystal structure, the SBS is
shielded by a C-terminal tail (C-tail) (Wang et al., 2008). Tail
movements simultaneously expose the SBS and the C-terminal
RDEL, allowing interaction with the KDEL receptors (KDELR)
and, hence, the retrieval to the ER of the chaperone and its client
proteins (Anelli et al., 2003; Cortini and Sitia, 2010; Vavassori
et al., 2013).
We demonstrated recently that the pH gradient existing along
the early secretory compartment (ESC), a term used herein to
define the ER, ER–Golgi intermediate compartment (ERGIC) and
Golgi complex, regulates C29 protonation and, consequently,
ERp44 tail opening (Vavassori et al., 2013). In the closed state,
C29 is concealed in the interface between domain-a and the C-
tail, forming the hydrogen bonds with the side chains of T369 and
S32 and the main chain amides of F31 and S32. At lower pH,
however, the hydrogen bonds are significantly weakened,
probably due to the protonation of the C29 thiol group, leading
to the release of the C-tail. Such pH-dependent conformational
change is advantageous in the regulated Golgi to ER transport of
client proteins by ERp44. Besides C29, T369 and S32, we also
noted that five histidine residues located at the border between the
domain-b9 and the C-tail are highly conserved in the ERp44
family proteins (Fig. 1A). To test the possibility that these
residues could also contribute in modulating ERp44 activity, we
here generated deletion and replacement mutants and analyzed
their activity in vitro and in vivo. Our data reveal a new
mechanism controlling the binding of both clients and KDELR by
ERp44 at ER–Golgi interface. We also show that O-glycosylated
ERp44 can be secreted by certain cell types.
RESULTS
In the available ERp44 crystals, part of the C-tail (residues 332–
350) is not resolved due to the lack of electron density (Wang
et al., 2008). Two histidine residues at the beginning of this
unstructured fragment (332–333) and additional ones in the
upstream helices (299, 323 and 328) are highly conserved in
ERp44 (Fig. 1A), as are the surrounding sequences. To
investigate the potential regulatory role of this histidine-rich
region, we first replaced residues 326–350 with a short spacer
(SGSG) to generate the DHis mutant (see supplementary material
Fig. S1A for details) and investigated its in vitro reactivity with
maleimide modified with polyethylene glycol 2000 (MalPEG)
(Fig. 1B) or 1-anilinonaphthalene-8-sulfonate (ANS) (Fig. 1C) as
a function of pH. ERp44 contains two unpaired cysteine residues
(C29 and C63) and four cysteine residues engaged in structural
disulfide bonds (C160–C212 and C272–C289 in domains b and
b9, respectively) (Wang et al., 2008). In a preceding study, we
found that C29 was the primary residue that reacts with MalPEG,
whereas C63 was also modifiable, although with much lower
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Fig. 1. pH-dependent conformational changes of ERp44 DHis in vitro. (A) Sequence conservation in the proximal part of the ERp44 C-tail. ClustalW2
alignment of the histidine-rich region and of the first part of the C-terminal tail of ERp44 reveals high sequence conservation in different organisms. Three
histidine residues reside in the tail (B, C and D, highlighted here in red) and two in the domain-b9 (A and A9, in pale blue). A, B and C are the most conserved
histidine residues, whereas A9 and D are absent in arthropods. The unstructured region in the crystal and the region deleted in the DHis mutant are indicated by
blue and red brackets. (B) pH-dependent accessibility of ERp44 cysteine 29. Upon in vitro alkylation with MalPEG (10 min at room temperature), ERp44
undergoes an easily detectable mobility shift in SDS-PAGE, indicating the accessibility of C29 to MalPEG (upper two panels) (Vavassori et al., 2013). The
percentage of MalPEG-bound ERp44 was plotted as a function of pH (lower panel). Clearly, lowering the pH increases the accessibility of C29 to MalPEG in
the DHis mutant as well as in wt ERp44. (C) pH-dependent tail movements in wt and DHis ERp44 compared by ANS binding in vitro. ANS fluorescence spectra
were measured for ERp44 wt or DHis. The exposure of hydrophobic surfaces correlates with increased and blue-shifted ANS fluorescence (Vavassori et al.,
2013). In this assay, ERp44 wt and DHis also show similar pH-dependent changes.
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efficiency (Vavassori et al., 2013). In the DHis mutant, the C-tail
was still long enough to shield C29 and the surrounding
hydrophobic patches at pH.7.0 (Fig. 1B,C). Even after
deletion of the His-rich loop, however, more MalPEG was
bound to ERp44 and the ANS fluorescence peak was blue-shifted
and enhanced upon lowering the pH. These data suggested that
in vitro C29 and the hydrophobic regions in DHis became
exposed at pH values encountered in the Golgi (6.5), as we
previously demonstrated for wild-type (wt) ERp44 (Vavassori
et al., 2013).
Fig. 2. The histidine-rich loop regulates accessibility of the active site and RDEL motif in vivo. (A) ERp44 mutants lacking the histidine-rich loop are
secreted. The indicated HeLa transfectants were cultured for 4 h in fresh medium, and aliquots from lysates (In) and supernatants (Sec) analyzed under
reducing conditions by western blotting with anti-HA antibodies. The first two lanes (Mock) show cells transfected with an empty plasmid. The arrowhead points
at secreted DHis ERp44. Red asterisks point at background bands recognized by anti-HA antibodies. Albeit not elegant, these unwanted bands provide
good loading controls. In all western blot analyses, molecular mass markers were used (see also Fig. 5): the red and blue bands indicate the migration of the 70-
and 50-kDa markers. (B) Residual retention of ERp44 DHis is due to KDELR activity. Aliquots from lysates (In) and spent media (Sec) were collected from
HeLa transfectants (treated as in A) and analyzed under reducing conditions by western blotting with monoclonal anti-ERp44 antibodies (36C9) that recognize
also endogenous ERp44. The black and red arrows point to endogenous and HA-tagged overexpressed ERp44 molecules, respectively. Note that deletion
of the C-terminal RDEL allows complete DHis secretion, whereas no endogenous ERp44 is detectable extracellularly. (C) ERp44 DHis is more efficient in
retaining Ero1a in a pH-independent manner. HeLa cells were co-transfected with ERp44 variants and Ero1a as indicated and the pH gradient in the ESC was
altered by GPHR silencing (– lanes show cells treated with irrelevant siRNA) as described previously (Vavassori et al., 2013). Aliquots from lysates (In) and
culture media (Sec) were collected and analyzed by western blotting using sequential staining of the same filter with anti-HA and anti-Myc antibodies to detect
ERp44 or Ero1a, respectively, as indicated. Note that less Ero1 is secreted out of cells expressing the DHis mutant, although its intracellular level is lower
than that of wt ERp44. A higher exposure of the secreted samples is shown to detect the small amounts of Ero1a secreted out of cells expressing the DHis
mutant. Intracellular and secreted proteins were quantified by densitometric analyses, and the mean fold of induction of Ero1a secretion upon GPHR
silencing calculated relative to controls (right panel). Data represent the mean6s.d. of eight or more experiments like the one shown in the left panel. (D) Client-
induced retention of DHis. Aliquots of lysates (In) and supernatants (Sec) of the indicated HeLa transfectants were analyzed as above. Note that much less
ERp44 DHis is secreted in the presence of Ero1a, and vice versa. (E) Secretion of ERp44 DHis is inhibited by client proteins (Ero1a and mDCH1).
Secretion of DHis in the presence or absence of overexpressed Ero1a or mDCH1 was analyzed as above. To quantify secretion, we calculated the ratios between
the DHis bands detected extra- and intra-cellularly after 4 h cultivation in fresh medium. To facilitate the comparison amongst different transfectants, the values
obtained for wt ERp44 and DRDEL were arbitrarily set at zero and 100, respectively. Histograms show the mean6s.d. for three or more experiments.
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The histidine-rich loop regulates the accessibility of the
active site and RDEL motif in vivo
Even though ERp44 DHis behaved similarly to wt ERp44 in vitro,
the mutant did show evident phenotypes in vivo. Indeed, DHis
was partially secreted by HeLa cells (Fig. 2A, lane 6, black
arrowhead), suggesting lower RDEL accessibility. Accordingly,
the double mutant DHis/DRDEL was secreted at levels similar to
ERp44 DRDEL (Fig. 2B). Pulse-chase assays (supplementary
material Fig. S2A) confirmed that the DHis mutant was secreted
by HeLa transfectants, and not degraded to a significant extent.
Taken together, these findings indicate that in the absence of the
histidine loop the RDEL motif interacts less efficiently with its
cognate receptors.
Next, we investigated whether the DHis mutant maintained the
ability to prevent the secretion of Ero1a. Like Prx4, Ero1a also
lacks a KDEL motif and is retained inside cells through
interactions with PDI or ERp44 (Kakihana et al., 2013; Otsu
et al., 2006). Secretion assays clearly demonstrated that: (i) DHis
was in part secreted (Fig. 2A), (ii) DHis was more efficient than
Fig. 3. Deletion of histidine-rich loop favors accumulation of ERp44 in
distal ESC stations. (A) Steady-state localization. HepG2 transfectants
expressing HA-tagged wt and DHis ERp44 were analyzed by
immunofluorescence with anti-HA antibody (green). The blue staining (DAPI)
was used to detect nuclei. Note that much less green staining is detected in
the nuclear membrane or peripheral ER in DHis transfectants, as compared
to cells expressing wt ERp44. (B) Client-induced relocalisation of DHis to the
ER. Co-expressing Ero1a–GFP, but not sGFP–RDEL, causes the re-
localization of DHis in the ER. HepG2 cells were co-transfected with Halo-
tagged ERp44 DHis and sGFP–RDEL or Ero1a–GFP and then decorated
with a Halo ligand (red signal). Clearly, no colocalization is detectable
between sGFP–RDEL (green) and ERp44 DHis (red), whereas expression of
Ero1a–GFP also causes DHis to localize in the ER, yielding a reticular yellow
staining (bottom right panel). Scale bars: 5 mm (A); 15 mm (B).
Fig. 4. Replacing conserved histidines causes O-glycosylation and
secretion of ERp44. (A) 3D localization of conserved histidine residues. The
panel highlights the 3D crystal structure of ERp44 with the C-tail in green.
Red letters (A, A9, B, C and D) point at the position of the five histidine
residues. Histidine residues C and D are located at the beginning of an
unstructured histidine loop (332–350) which, as the five C-terminal DRDEL
residues, is not resolved in the crystal. (B) Replacement of histidine
residues induces secretion of modified ERp44. Aliquots from lysates (In) and
culture media (Sec) were collected from HeLa transfectants expressing the
indicated ERp44 variants and blots were stained with anti-HA antibody.
Similar experiments were performed for other histidine mutants (data not
shown). Note that anti-HA antibodies specifically detect two bands in the
lysates of the BCD and ABCD mutants, of which only the upper one is
secreted (black arrow). The green arrow points at the only intracellular band
recognized in transfectants expressing wt ERp44. Red asterisks point at
some background bands recognized by anti-HA antibodies, which provide
useful loading controls. (C) His replacement mutants are retrieved more
efficiently upon Ero1a co-expression. ERp44 secretion was quantified as
described in Fig. 2E in HeLa cells expressing the indicated ERp44
mutants alone or with Ero1a. The histograms show the percentage of
secreted ERp44 for the different mutants. The data represent the mean6s.d.
of three or more experiments in the presence of Ero1a. Secretion efficiency
was calculated as described in legend to Fig. 2E.
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wt ERp44 in preventing Ero1a secretion (Fig. 2C, lanes 3 and 5),
and (iii) paradoxically, the co-expression of a client (Ero1a)
inhibited the secretion of the retainer (DHis, Fig. 2D, lanes 5
and 6). These findings suggest that client binding could favor
RDEL exposure in DHis. The ‘client-induced retention’ of DHis
was evident upon co-expressing not only Ero1a (Fig. 2E) but also
Ig-mDCH1, another known ERp44 substrate (Anelli et al., 2007;
Ronzoni et al., 2010; Vavassori et al., 2013).
To analyze the pH dependency of DHis in living cells, we
silenced the Golgi pH regulator [GPHR (Maeda et al., 2008)],
specifically raising the pH in the Golgi (Vavassori et al.,
2013). Owing to the unavailability of anti-GPHR antibodies,
the efficiency of silencing was monitored by RT-PCR assays
(supplementary material Fig. S2B). As previously observed
(Vavassori et al., 2013), neutralizing the ER–Golgi pH gradient
allowed Ero1a secretion (Fig. 2C, lanes 1 and 2), as was the case
in cells overexpressing wt ERp44 (Fig. 2C, lanes 3 and 4). In
contrast, basification of the cis-Golgi did not affect the capability
of DHis to retain Ero1a (Fig. 2C, lanes 5 and 6).
Thus, deletion of histidine-rich loop allowed secretion of
ERp44 unless high-affinity client proteins were co-expressed. At
the same time, it increased its ability to retain Ero1a (Fig. 2C)
and Ig-mDCH1 (data not shown) and limited its pH dependency
(Fig. 2C). Secreted Ero1a could be detected only upon
overexposure of the Western blot, such was the efficiency of
DHis in retaining the oxidase.
Deletion of histidine-rich loop favours accumulation of ERp44
in distal ESC stations
How could ERp44 DHis be so efficient in retaining Ero1a?
Endogenous ERp44 is mainly localized in the ERGIC and cis-
Golgi, partly owing to interactions with the lectin ERGIC-53
(Anelli et al., 2007). In contrast, overexpressed ERp44
accumulates in the ER (Anelli et al., 2002; Anelli et al., 2003).
The DHis mutant localized more distally than wt ERp44 when
expressed in the secretory HepG2 cell line (Fig. 3A). Organelle
fractionation assays confirmed that DHis accumulated in the
ERGIC and cis-Golgi, a localization that would favor capture of
clients destined to be retrieved (data not shown).
Based on the earlier observation that overexpression of high-
affinity client proteins prevented secretion of DHis, we
investigated whether the presence of Ero1a–GFP could alter the
subcellular localization of the DHis mutant. An ER-resident
protein that does not bind ERp44 (sGFP–RDEL) was used as a
control (Fig. 3B). Clearly, the co-expression of Ero1a–GFP, but
not sGFP–RDEL, caused re-localization of DHis into the ER.
These data reinforced the notion that interactions with high-
affinity clients (e.g. Ero1a) keep the tail of ERp44 in an open
conformation, favoring RDEL exposure and KDELR-dependent
retrieval of the complex to the ER.
Conserved histidines regulate C-tail movements in vivo
Considering their conservation fromHomo sapiens to Caenorhabditis
elegans (Fig. 1A), we replaced histidine residues 299, 323, 328,
332 and 333 (called hereafter A, A9, B, C or D, respectively) with
alanine residues, singularly or in combinations. The A and A9
residues are part of the domain-b9, whereas residues B, C and D are
located in the C-tail (Wang et al., 2008). Histidine residues A, A9
and B are part of structured 310 helices whereas histidine residues C
and D reside in a flexible loop (Fig. 4A) and are hence most likely
to be exposed to the solvent. A, B and C are conserved throughout
evolution. Single mutation of each of them allowed partial
secretion. In contrast, replacing the less conserved histidine
residues, A9 or D, had little, if any, effect (Table 1; data not
shown). Clearly, the more histidine residues were replaced, the
more ERp44 was secreted (Fig. 4B,C). Deleting the entire loop had
even stronger effects (Fig. 2A). Taken together, these results
suggest that in living cells the flexible His-rich loop is important to
favor tail movements leading to RDEL exposure in the absence of
high-affinity clients. Without this loop, the RDEL motif likely
remains less accessible to cognate receptors and as a consequence
the mutant is secreted. By contrast, co-expression of Ero1a
Table 1. Phenotypic characterization of ERp44 histidine mutants
Ero1a retentiona ERp44 secretionb
ERp44 variant Untreated GPHRi Alone Ero1a O-glyc. Subcellular localizationc
WT ++ + Undetectable Undetectable No ER–ERGIC
DRDEL 2 2 100%c 100% Yes Barely detectable
DHis ++++ ++++ 36% 9% No ERGIC–cis-Golgi
A ++ ND ,10% Undetectable Yes ND
A9 ND ,5% Undetectable Yes ND
B ++ ND ,10% No Yes ER–ERGIC
C ND ND ,10% ND Yes ER–ERGIC
D + ND ,5% Undetectable Yes ER–ERGIC
BC ++ ND <10% ,5% Yes ERGIC
BD + ND ,10% Undetectable Yes ND
CD +++ ++ ,10% Undetectable Yes ERGIC
BCD +++ ND 15–20% <5% Yes ERGIC–cis-Golgi
A9BCD +++ ND <10% <5% Yes ND
ABCD +++ ND 20–25% ,10% Yes ERGIC–cis-Golgi
The data summarize the main features of the mutants described in this paper, including the capability of retaining overexpressed Ero1a, and of being secreted in
different conditions, and their basal subcellular localization. GPHRi , GPHR-silenced cells; ND, not determined.
aScoring is relative to the mutants with the highest (DHis ++++) and lowest (DRDEL 2) efficiency. The former efficiently retains Ero1 even when expressed at
rather low levels (see Fig. 2C).
bFor ERp44 secretion, scoring is relative to a maximum (100%, DRDEL) and a minimum (0%, wt ERp44), which is undetectable in the spent media (4 h) of our
HeLa transfectants. Precise values are given only for DHis, for which the experiment has been repeated over 10 times.
cSubcellular localization was determined by immunofluorescence, based on data like those shown in Fig. 3 and and supplementary material Fig. S3. Owing to its
rapid secretion (Anelli et al., 2007), the DRDEL mutant is not easily detectable inside cells unless radioactive pulse-chase assays are utilized (see
supplementary material Fig. S2).
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strongly inhibited secretion of the mutants (Fig. 4C), as described
earlier for DHis (Fig. 2D). Given that ERp44 is a pH-regulated
chaperone, it is not surprising that the histidine residues (whose
intrinsic pKa is near neutral) contained in or immediately upstream
the loop contribute to the control of RDEL exposure in vivo. In line
with their high evolutionary conservation, histidine residues A, B
and C appear to be particularly important in regulating tail
movements.
Secreted ERp44 is O-glycosylated at threonine 338
Western blotting analyses revealed the presence of two bands in
the lysates of the BCD and ABCD mutants, of which only the
upper was secreted (Fig. 4B, see arrows). Although ERp44 has no
potential N-glycosylation sites, mutants that escaped KDELR-
dependent retrieval could undergo O-glycosylation in the Golgi.
To ascertain whether this was indeed the case, we treated HeLa
transfectants with brefeldin A (BFA), a drug known to induce the
retrograde transport of Golgi enzymes to the ER (Lippincott-
Schwartz et al., 1989). The electrophoretic mobility of wt and
BCD ERp44, but not of DHis, was lower after BFA treatment
(Fig. 5A, compare lanes 3, 7 and 10). Treatment with O-
glycosidase restored faster migration (lane 4) and abolished the
doublet observed in the BCD mutant (lane 9), demonstrating that
ERp44 can undergo O-glycosylation before being secreted. In
contrast, DHis ERp44 was not modified in the presence of BFA,
indicating that either the target residue was deleted in this mutant
or the replacement caused its inaccessibility to O-glycosyl
transferases.
Notably, endogenous ERp44 was also modified upon BFA
treatment (Fig. 5B, see black arrow). Non-reducing gels revealed
that O-linked glycosylation did not prevent ERp44 from forming
covalent complexes with its clients (Fig. 5B, see lanes 3 and 4).
The fact that most wt ERp44 was not modified in normal
conditions implied its retrieval before the modification occurs. In
silico prediction programs (Hamby and Hirst, 2008; Steentoft
et al., 2013) pointed at threonine residues 338 and 340 as possible
substrates of O-glycosylation. Both are located within the loop
deleted in DHis, which would explain why this mutant is not O-
glycosylated. Replacing the most conserved one, T338, with
alanine in a mutant that was in part secreted and modified
(ABCD) was sufficient to prevent the processing (Fig. 5C, lanes 5
and 6). Failure to undergo O-glycosylation did not prevent
secretion (Fig. 5D). Thus, ERp44 can be O-glycosylated at T338.
Despite the fact that in the experiment shown in Fig. 4B the
BCD and ABCD mutants were secreted at similar levels, more O-
glycosylated accumulated intracellularly in the former mutant.
Fig. 5. Mapping client-induced retrieval of His replacement
mutants with respect to O-glycosylation. (A) Secreted ERp44 is
O-glycosylated. HeLa cells transfected as indicated were treated
with (lanes 3, 4, 7, 10) or without brefeldin A (BFA) for 4 h to
determine whether retrieval of Golgi enzymes to the ER caused
processing of ERp44. Aliquots from the lysates were digested with
(lanes 2, 4, 6, 9) or without O-glycosidase (see Materials and
Methods), resolved by gel electrophoresis and blots stained with
anti-HA antibody. The blue band indicates the migration of the 50-
kDa marker. (B) Endogenous ERp44 can also be O-glycosylated and
form covalent complexes with client proteins. Untransfected HeLa
cells were treated with BFA as above and resolved under reducing
(lanes 1–2) and non-reducing (lanes 3–4) conditions before blotting
and staining with 36C9 monoclonal anti-ERp44 antibodies.
Molecular mass markers (250, 130, 70 and 50 kDa) are shown in the
center lane (MW). (C) ERp44 is O-glycosylated on threonine 338.
Aliquots from the lysates of the indicated HeLa transfectants treated
with or without BFA were analyzed by western blotting with anti-HA
antibody. (D) Replacing threonine 338 does not impede secretion of
the ABCD mutant. The supernatants of cells transfectants were
resolved under reducing conditions and stained with anti-HA
antibody. The green arrow points at the secreted product of the
T338A. This mutant displays faster mobility than the O-glycosylated
DRDEL secretory products (black arrow).
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These findings suggest that BCD could also be more efficiently
retrieved from stations downstream the compartment where O-
glycosylation takes place. The lower pH of these downstream
stations could increase the exposure of RDEL (Vavassori et al.,
2013) and/or the activity of KDELR (Wilson et al., 1993).
Exploiting O-glycosylation to map where ERp44 binds
its clients
As described in Fig. 2D and Fig. 4C, overexpression of high-
affinity ERp44 clients prevented the secretion of histidine
mutants, likely increasing RDEL accessibility. The notion that
these histidine mutants could be O-glycosylated prompted us to
determine whether the binding of different clients occurred before
or after the compartment where this modification takes place.
Substrates binding before encountering the glycosylating enzymes
would increase the lower molecular mass band accumulating in
cell lysates, whereas O-glycosylated forms would prevail if the
interaction occurred in downstream stations. The ABCD mutant
was hence expressed with Ero1a, Prx4, Ig-mDCH1, adiponectin or
Sumf1, and the unmodified:modified band ratios were calculated
(Fig. 6A). Clearly, expression of Ero1a and Prx4 favored
accumulation of the unglycosylated species. In contrast, Sumf1
induced retrieval of ABCD after it had been processed by O-
glycosyl transferases. mDCH1 and adiponectin had intermediate
effects (Fig. 6B). These observations might reflect differences in
the binding affinities or pH dependency of the interactions between
Fig. 6. Client-induced retrieval of ERp44. (A) Sumf1 can also bind ERp44 after O-glycosylation. HeLa cells were co-transfected as indicated. Aliquots from the
lysates were then resolved by SDS-PAGE and blots stained with anti-HA. Note the accumulation of non-glycosylated histidine mutants in the lysates of cells co-
expressing Ero1a or Prx4. Instead, Sumf1 expression allows significant accumulation of O-glycosylated ABCD ERp44. (B) Sequential client-induced
retrieval of ERp44 histidine mutants. The histograms show the ratio between modified and unmodified ABCD ERp44 in the presence of Ero1a, Prx4, Sumf1, Ig-
mDCH1 or adiponectin (APN). Data represent the mean6s.d. of three or more experiments. (C) Endogenous ERp44 is O-glycosylated in primary endometrial
cells. Aliquots of the lysates obtained from endometrial cells in their proliferative (lanes 4–5) or secretory (lanes 3, 6–7) phase (Di Blasio et al., 1995) were
digested with (lanes 5, 7) or without (lanes 3, 4, 6) O-glycosidase and resolved by gel electrophoresis under reducing conditions. Note that upon digestion,
the doublet visible in untreated samples collapses into a single higher mobility band, which comprises un-glycosylated and de-glycosylated ERp44 (green
arrow). The black arrow points at the O-glycosylated species, the main form accumulating in HeLa (lane 2) or endometrial (lane 3) cells after treatment with BFA.
(D) Endogenous ERp44 is secreted by endometrial stromal cells. Aliquots from the lysates or spent media (48 h) corresponding to 86104 or 76105
endometrial cells in their secretory phase were immunoprecipitated (IP) with the 36C9 monoclonal anti-ERp44 antibody, resolved under reducing conditions and
stained with rabbit anti-ERp44 antibody (JDA1). Lanes 1 and 2 show one-third of the spent medium before (Input) or after (L.O., left over) immunoprecipitation.
The band migrating above the 50-kDa marker is BSA, which is highly abundant in fetal calf serum. Cross-linked beads were used as a negative control (lane 4).
Endogenous ERp44 is clearly detectable in the culture medium and migrates with a molecular mass similar to the O-glycosylated ERp44 species present
intracellularly (black arrow).
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ERp44 and its clients. In addition, other factors, including
molecules binding to the histidine-rich region, could regulate the
strength and location of the interactions between ERp44 and its
clients.
The above data demonstrated that certain ERp44 mutants could
be O-glycosylated. To verify the physiological relevance of
ERp44 processing, we screened a wide panel of cell lines and
tissues (E. Yoboue, T.A., S.S. and R.S., data not shown). ERp44
yielded a doublet band in primary endometrial cells obtained
from normal volunteers (Fig. 6C, lanes 4 and 6). The mobility of
the upper band (highlighted by a black arrow) is comparable to
the one accumulating upon treatment with BFA (lanes 2 and 3).
Treatment with O-glycosidase collapsed the doublet into a single
band (lanes 5–7, see green arrow), confirming that endogenous
ERp44 can undergo O-glycosylation. Notably, the relative
abundance of O-glycosylated ERp44 was higher in endometrial
cells in the secretory phase than in the proliferative phase (Di
Blasio et al., 1995). Processed ERp44 was detected in the spent
medium of secretory endometrial cells (Fig. 6D, lanes 1 and 3).
DISCUSSION
To promote productive folding, chaperones must bind and release
their clients. Some are regulated by ATP and others by the redox
state, whereas ERp44 exploits the pH gradient existing between
the ER and the Golgi (Vavassori et al., 2013, and references
therein). How does ERp44 sense pH? We show here that highly
conserved histidine residues in the ERp44 C-tail provide a second
sensing device that acts coordinately with the C29 protonation
mechanism previously shown to regulate ERp44 cycling and
activity within the ESC (Vavassori et al., 2013).
Deletion or replacement of the key conserved ERp44 histidine
residues had notable consequences in vivo. In fact, it caused
secretion of the histidine mutants by the cells, likely owing to a
reduced accessibility of the RDEL motif to KDELR in the Golgi.
Accordingly, co-expression of clients that would bind to the SBS
and force RDEL exposure restored their retrieval (see Fig. 7). In
contrast, deletion or mutation of the conserved histidine residues
had marginal effects in vitro (Fig. 1A, and our unpublished
results), indicating that additional ‘histidine-region-binding
factors’ regulate ERp44 in vivo (Fig. 7). Such factors could
bind ERp44 in the ER and limit its forward transport, accounting
for the enrichment of the histidine mutants in post-ER
compartments (Fig. 3). Alternatively, the mutants might be
present and/or be activated in distal compartments to assist in
tail opening (and consequent RDEL exposure) in the absence of
clients. Thus, whereas the C29-based tail regulation is intrinsic to
ERp44 and can be revealed in vitro, the histidine-dependent
mechanisms are evident only in vivo as they require additional
regulatory elements.
Histidine mutants are more efficient than wt ERp44 in
preventing Ero1a secretion. This feature was rather unexpected
because they are partly secreted, and might reflect their increased
specificity towards Ero1a. Some clients would be more effective
than others in competing with the C-tail for the substrate-binding
site in the histidine mutants, which likely have a higher kinetic
barrier for tail opening. In this context, Ero1 and Prx4 bind to
ERp44 mainly before it undergoes O-glycosylation, whereas
Sumf1 can also interact afterwards (Fig. 6A,B). These
observations suggest that different proteins could be deposited
sequentially in the exocytic pathway, depending on their affinity
for ERp44 or on the pH dependency of the chaperone–client
interaction. Along these lines, it is interesting that most ERp44
substrates and/or partners that are ER-resident enzymes (Ero1a,
Prx4 and Sumf1) lack a C-terminal KDEL sequence and rely on
protein–protein interactions for their intracellular localization.
Thus, the relative abundance of ERp44 is likely to regulate their
localization and activity in and between different cells (Pagani
et al., 2001; Swiatkowska et al., 2010; Zito et al., 2007).
Consistent with its many intracellular functions (Cortini and
Sitia, 2010), ERp44 is efficiently retained by most of the cell
types analyzed. Notably, however, endometrial cells secrete O-
glycosylated ERp44 and do so more efficiently in the secretory
phase of the menstrual cycle (Fig. 6C,D). These findings also
suggest possible role(s) for ERp44 in intercellular dialogues.
Accordingly, ERp44 can be released by platelets following
activation (Holbrook et al., 2010). It is thus possible that other
mechanisms, including pH regulation, regulate the localization of
ERp44 and in turn of many of its clients and interactors.
Controlling the release of ERp44 might have relevant
pathophysiological implications.
MATERIAL AND METHODS
Reagents and cell cultures
Chemicals were from Sigma, unless otherwise indicated. Monoclonal
and polyclonal anti-ERp44 antibodies (36C9 and JDA1 respectively),
Fig. 7. Schematic model of ERp44 regulation. The lower pH encountered
by ERp44 as it proceeds along the early secretory pathway, favors opening
of the C-tail and KDELR binding regardless of the presence or absence of
high-affinity client proteins. Accordingly, ERp44 mutants that bind few, if any,
substrates in cells (e.g. ERp44C29S; Anelli et al., 2003) are not secreted. By
contrast, mutants lacking key conserved histidine residues or a loop at the
border between the domain-b9 and the tail (star) bind poorly to KDELRs,
proceed towards the extracellular space and are O-glycosylated. Client
binding induces KDELR-dependent retrieval of histidine mutants before
(Ero1, Prx4) or after (Sumf1) O-glycosylation takes place. Given that histidine
mutants remain pH sensitive in vitro, we hypothesize that histidine-region
binding factor(s) (HRBF) favor tail movements in vivo, allowing efficient
RDEL exposure.
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anti-Myc (9E10) and anti-GM130 were as previously described (Anelli
et al., 2002; Anelli et al., 2007). Polyclonal anti-PDI was a kind gift of
Ineke Braakman (Utrecht, The Netherlands). Unconjugated goat anti-
mouse-Ig antibodies were from Southern Biotechnology Associates, Inc.
(Birmingham, AL), and horseradish peroxidase (HRP)-bound goat anti-
mouse-Ig and anti-rabbit-Ig were from Jackson ImmunoResearch
Laboratories, Inc. Fluorescent goat anti-mouse- and anti-rabbit-IgG
(H+L) conjugated to Alexa Fluor 700, 647, 546 and 488 were from
Invitrogen Molecular Probes (Eugene, Oregon, USA).
HeLa and HepG2 cell lines were purchased from the ATCC. Tissue
culture, transfection, and silencing were performed as described
previously (Anelli et al., 2007). HepG2 cells were transfected by
FugeneHD (Promega Corporation, Madison, USA) following the
manufacturer’s instructions. Primary endometrial cells were collected
from healthy donors and cultured as described by Di Blasio at al. (Di
Blasio at al., 1995). All women provided informed consent for their
clinical data and samples to be used for research purposes. The San
Raffaele Hospital Ethical Committee approved the study protocol.
Plasmids and vectors
The cDNA encoding human ERp44 without the signal sequence from
pGEX-4T-1-ERp44 and the vector for sGFP–RDEL expression were as
previous described (Vavassori et al., 2013). Vectors driving the
expression of human ERp44 were as previously described (Anelli
et al., 2002). Mutants were obtained by PCR or by site-directed
mutagenesis (SDM) using the primers listed in supplementary material
Table S1. All the primers were purchased from PRIMM srl (Milano,
Italy). Plasmids encoding mutated secretory Ig-m chains (mDCH1) were
as previously described (Cenci et al., 2006; Mattioli et al., 2006).
Halo ERp44 vector construction
A Halo tag was inserted after the ERp44 leader sequence cleavage site as
follows: ERp44 without tags was cleaved from the pcDNA3.1 (2) vector
by XhoI and KpnI and inserted in pBlueScript II KS (+). A SgfI site was
inserted after the leader sequence cleavage site by PCR (p44sgfI Fw, 59-
CCTGTAACAACTGAAATAGCGATCGCTGAAATAACAAGT-39 and
p44sgfI Rv, 59-ACTTGTTATTTCAGCGATCGCTATTTCAGTTGTT-
ACAGG-39). The PCR product was then re-inserted into pcDNA 3.1 (2)
vector following XhoI and KpnI digestion. In pHTN-HaloTagCMV-
neoVectorH (Promega Corporation), HaloTag was mutagenized inserting a
SgfI site at the N-terminal extremity by PCR (pHTN SgfI Fw, 59-
GCCGCGATCGCTGAAGCAGAAATCGGTAACTGGCTTTCCATTC-
39 and pHTN SgfI Rv: 59-GGAAGCGATCGCGTTATCGCTCTG-39).
Halo-ERp44 was obtained by ligating SgfI fragments overnight at 16 C˚,
which were then screened by SmaI digestion and validated by sequencing.
Western blotting, densitometric quantifications and
biochemical techniques
Fluorograms or western blot images were acquired with the Chemidoc-it
Imaging System (UVP, Upland, CA) or with FLA-900 Starion (Fujifilm
Life Science, USA) and quantified with Image J as described previously
(Anelli et al., 2007).
To assess O-glycosylation, aliquots from HeLa cell lysates were
denatured at 95 C˚ for 10 min in glycoprotein denaturing buffer (New
England BioLabs Inc.), digested with neuraminidase and O-glycosidase
overnight at 37 C˚ and analyzed by western blotting with specific
antibodies.
As loading controls for western blotting assays, we used Ponceau
and/or anti-tubulin antibody staining. In some experiments, some
nonspecific bands were present in blots stained with anti-HA antibody
(see for instance red asterisks in Figs 2 and 4). Signal intensity was
quantified with Image J. The loading of the lanes rarely, if ever,
differed more than 5%, with the exception for O-glycosidase treatment
where the protein levels were about 20% lower with respect to BFA or
untreated samples.
Immunoprecipitation of endogenous ERp44 from primary endometrial
cell lysates and spent medium was performed with Sepharose-
immobilized 36C9 as previously described (Anelli et al., 2012).
Wild-type and mutant ERp44 were purified and analyzed as described
previously (Masui et al., 2011; Vavassori et al., 2013). Briefly, ANS
fluorescence spectra were recorded in 1-cm cuvettes on a Hitachi F-2500
spectrofluorometer. ERp44 and mutants (5 mM) were mixed with
100 mM ANS in 20 mM Tris-HCl (pH 7.5) or MES (pH 6.5)
containing 150 mM NaCl and incubated at 20 C˚ for 10 min before
measurement.
For maleimidyl PEG-2K modification of ERp44 C29, each ERp44
derivative (5 mM) was incubated on ice for 30 min in various pH buffers
containing 100 mM sodium phosphate and 150 mM NaCl, followed by
incubation with maleimidyl PEG2K (300 mM) for 10 min at room
temperature. The reaction was stopped by the addition of 5%
trichloroacetic acid, and the protein pellet was washed with acetone
and dissolved in buffer containing 50 mM Tris-HCl (pH 7.0) and 1%
SDS before loading onto a reducing SDS gel (10%).
Radioactive pulse-chase assays
Cells were starved for 5 min in cysteine- and methionine-free DMEM
(GIBCO, Invitrogen), pulsed for 10 min with [35S]cysteine and
[35S]methionine (Easy Tag, Perkin-Elmer), washed twice and chased in
complete medium. After the indicated chase times, cells were treated
with 10 mM NEM and lysed in RIPA buffer as described previously
(Vavassori et al., 2013). Immunoprecipitates were resolved by SDS-
PAGE under reducing conditions, transferred onto nitrocellulose and
filters visualized by autoradiography with FLA900 Starion (Fujifilm Life
Science, Tokyo, Japan).
Immunofluorescence
HepG2 cells were plated on 15-mm glass coverslips and transfected.
After 48 h of transfection, cells were fixed in 4% PFA, permeabilized
with 0.2% Triton X-100 and stained with different antibodies. For Halo-
tagged proteins, cells were incubated overnight with 10 nM TMR Halo
ligand (Promega Corporation). Samples were analyzed on an Olympus
inverted fluorescence microscope (model IX70) with DeltaVision RT
Deconvolution System (Alembic, HSR, Milano). After deconvolution,
images were processed with Adobe Photoshop CS4 (Adobe Systems
Inc.).
GPHR silencing
Total RNA from untreated and GPHR silenced (GPHRi) HeLa
transfectants was extracted with Tryzol from Thermo Fisher
Scientific (Waltham, USA) following the manufacturer instructions
and its quality was checked by OD260:OD280 readings and
electrophoresis. An aliquot of each sample was retro-transcribed by
Super-Script II kit (Invitrogen, USA). Real-time PCR was performed
with Syber green Master Mix in 25 ml of volume by ABI7900 (Applied
Biosystem, Foster City, CA). Finally data were analyzed by SDS 2.1
software (Applied Biosystem).
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Schematic representation of the ERp44 mutants used in this study
The red rectangle at N-terminus represents the tag (HA or Halo), placed immediately after the 
signal sequence. The signal sequence, tag and RDEL motif are absent in the vectors used for 
E.coli expression. Black stars indicate point mutations. The ΔHis mutant was generated by 
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A. ERp44 ∆His is secreted. HeLa transfectants were pulsed with radiolabeled amino acids 
and chased in cold medium. At the indicated times, aliquots from the lysates (In) and 
supernatants (Sec) were immunoprecipitated with anti-HA antibody and analyzed by gel 
electrophoresis. Intracellular ERp44 levels were quantified and the values depicted in 
the graph shown on the right. While the intracellular pool of ∆His decreases, the total 
HA signal (In plus Sec) remain rather constant, indicating that the mutant is not
degraded to a significant extent.
B. GPHR silencing. The efficiency of silencing was verified  by RealTime PCR. The average 
of five experiments are represented in the graph with SEM .
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Localization of HA-tagged ERp44 mutants. HepG2 transfectans expressing HA-ERp44 ∆His (A) or different histidine 
mutants (B) were decorated with anti-HA (green signal) and with different ESC markers (in red, either ERGIC-53 or 
GM130).  ∆His and ABCD colocalize mainly with GM130 and partially with ERGIC-53, whilst BC colocalizes preferentially 
with  ERGIC-53.
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Template ERp44
FW
RV
FW
RV
FW1
RV1
FW
RV
FW
RV
FW
RV
FW
RV
FW
RV
FW
RV
FW
RV
FW
RV
FW
RV
FW
RV
primers
GCGCCTCGAGTTAATCCCTCAATAGAGTATACCTATAT
GCGCGCGGATCCGGTAGTCCTGAGAGAGCTCCTTC
GCGCGGATCCAGAATGTAAGTCAAATACGAA
ATCGCTATTGACAGCTTTAGAGCTATGTATGTGTTTGGAG
CTGCACAGAGAATTCCATGCTGGACCTGACCCAACTGAT
CTCCAAACACATACATAGCTCTAAAGCTGTCAATAGCGAT
GACTTACATTCTGGAAAACTGGCCAGAGAATTCCATCATGGAC
GTCCATGATGGAATTCTCTGGCCAGTTTTCCAGAATGTAAGTC
CACAGAGAATTCGCTCATGGACCTGAC
GTCAGGTCCATGAGCGAATTCTCTGTG
pET28
PCR 
cloning ERp44 ΔHis
CAACTCGAGCGTTACCATGCATCCTGCC
GCGGCGGTACCTTAAAGCTCATCTCGATCCCTC pcDNA ERp44 wt
cut and 
paste
CACCGCTAGCGAAATAACAAGTCTTGATACAGAGAAT
ERp44 ΔHis
ERp44 A (H299A)
ERp44 B (H328A)
ERp44 C (H332)
ERp44 D (H333A)
ERp44 CD                    
(H332-333A)
ERp44 BD                   
(H328-333A)
pcDNA ERp44 wt SDM
GACTTACATTCTGGAAAACTGGCCAGAGAATTCCATCATGGAC ERp44 BCD                 
(H328-332-333A)GTCCATGATGGAATTCTCTGGCCAGTTTTCCAGAATGTAAGTC
SDM
SDM
SDM
ERp44 BC                   
(H328-332A)
ATCAGTTGGGTCAGGTCCAGCATGGAATTCTCTGTGCAG
AAACTGGCCAGAGAATTCGCTCATGGACCTGACCCAACT
AGTTGGGTCAGGTCCATGAGCGAATTCTCTGGCCAGTTT
CTGGAAAACTGCACAGAGAATTCGCTGCTGGACCTGACCCAACTGATACAG
CTGTATCAGTTGGGTCAGGTCCAGCAGCGAATTCTCTGTGCAGTTTTCCAG
CTGGCCAGAGAATTCCATGCTGGACCTGACCCAACTGAT
ATCGCTATTGACAGCTTTAGAGCTATGTATGTGTTTGGAG
pcDNA ERp44 CD
ERp44 ABCD (H299-
328-332-333A)CTCCAAACACATACATAGCTCTAAAGCTGTCAATAGCGAT
GCTGCTGGACCTGACCCAGCTGATACAGCCCCAGGAGAG ERp44 
ABCD/T338ACTCTCCTGGGGCTGTATCAGCTGGGTCAGGTCCAGCAGC
Supplementary Table 1 List of the primers and methods (SDM, side directed mutagenesis; PCR, polymerase chain reaction) employed to generate the ERp44 mutants 
used in this study.
pcDNA ERp44 wt
pcDNA ERp44 wt
pcDNA ERp44 BCD
SDM
pcDNA ERp44 wt SDM
pcDNA ERp44 B
pcDNA ERp44 
ABCD SDM
pcDNA ERp44 B
pcDNA ERp44 wt
ATCAGTTGGGTCAGGTCCAGCATGGAATTCTCTGGCCAG SDM
SDM
SDM
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Abstract
Precise coordination of protein biogenesis, traffic and homeostasis within the early secretory compartment (ESC) is key for
cell physiology. As a consequence, disturbances in these processes underlie many genetic and chronic diseases. Dynamic
imaging methods are needed to follow the fate of cargo proteins and their interactions with resident enzymes and folding
assistants. Here we applied the Halotag labelling system to study the behavior of proteins with different fates and roles in
ESC: a chaperone, an ERAD substrate and an aggregation-prone molecule. Exploiting the Halo property of binding
covalently ligands labelled with different fluorochromes, we developed and performed non-radioactive pulse and chase
assays to follow sequential waves of proteins in ESC, discriminating between young and old molecules at the single cell
level. In this way, we could monitor secretion and degradation of ER proteins in living cells. We can also follow the
biogenesis, growth, accumulation and movements of protein aggregates in the ESC. Our data show that protein deposits
within ESC grow by sequential apposition of molecules up to a given size, after which novel seeds are detected. The
possibility of using ligands with distinct optical and physical properties offers a novel possibility to dynamically follow the
fate of proteins in the ESC.
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Introduction
To achieve their native structure, secretory and membrane
proteins exploit the vast array of chaperones and enzymes that
reside in the endoplasmic reticulum (ER), the port of entry into the
secretory compartment. Here, they undergo stringent quality
control [1,2]: only properly folded and assembled proteins are
given the green light and proceed along the secretory pathway.
Proteins that fail to attain their native state are eventually retro-
translocated to the cytosol for proteasomal degradation. Not all
proteins entering the ER are secreted or directed to the plasma
membrane. Even if in some conditions the flux of cargo can
become intense, resident proteins stop at the desired stations to
maintain organelle identity and guarantee function. For instance,
soluble ER residents are retrieved from downstream stations via
KDEL-Receptors [3].
The sophisticated systems deployed by cells to regulate this
intense traffic and prevent dangerous jams in ESC are unfortu-
nately not fully reliable. Sometimes, an overzealous quality control
can cause systemic loss of function diseases preventing the
transport of mutants that are nonetheless active. Unless promptly
degraded, moreover, these can condense in ESC and cause gain of
function diseases [4].
Secretory IgM are complex polymers [5] whose biogenesis
occurs stepwise in ESC [6]. Like other unassembled Ig-H chains,
secretory m (ms) interact with BiP via their first constant domain
(CH1). Assembly with Ig-L displaces BiP, and m2L2 complexes are
then slowly polymerized [7]. When CH1 is lacking, mDCH1
accumulate in a detergent insoluble form within dilated ESC
cisternae, also called Russell Bodies (RB) [8,9] providing a suitable
model system for Heavy Chain Disease (HCD [10] and references
therein) and ER storage disorders (ERSD [11]). We recently
identified some of the factors that modulate mDCH1 condensation
in living cells. For instance, over-expression of ERp44, a
multifunctional chaperone that mediates thiol-dependent quality
control of IgM subunits and other clients [12,13], stimulated the
accumulation of mDCH1 in RB [14].
To learn more about how cells handle different proteins in ESC,
we generated different chimeric proteins containing a Halotag
(Halo) derived from a Rhodococcus rhodochrous Haloalkane
dehalogenase whose active site has been engineered to covalently
bind fluorescently-labelled chloro-alkane derivatives [15,16]. With
respect to more conventional live-cell labelling based on fluores-
cent proteins the Halotag post-translational labelling system has
several advantages. First, it allows to using organic dyes such as
TMR (tetramethyl-rhodamine) or R110, that are brighter and
more photostable than fluorescent proteins [17] and whose
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fluorescence is relatively pH-insensitive [18]. By selecting suitable
ligands the same tag can be used for live cell microscopy,
immunofluorescence, Western Blotting, protein purification and
co-precipitation assays [16,17,19–26]. Moreover, the Halotag
allows following the accumulation and/or the degradation of the
protein of interest by two-color pulse/chase experiments with high
temporal resolution [27]. Lastly, the Halotag has the advantage of
not possessing glycosylation sites, that could affect folding and
transport of the chimeric proteins in the secretory compartment.
Another hybrid system, based on small molecules able to
covalently bind genetically specified proteins, is the tetracysteine
biarsenical system [28]. Unfortunately, due to the oxidative
environment of the ER, this system cannot be applied to the
study of secretory proteins.
In this work, after confirming that Halo folds and maintains its
activity in ESC without grossly perturbing the fate of the target
protein, we followed the condensation of Halo-mDCH1 in ESC and
analysed the growth and mobility of the resulting RB in vivo
exploiting the property of covalently binding ligands coupled to
different fluorochromes. Moreover, by appending the Halotag to
short- and long-lived ER residents and to transport competent
molecules, we show that it is possible to follow protein degradation
and secretion bypassing classic radioactive pulse and chase
techniques. Thus, Halo is a versatile non-invasive tool to follow
key events in the secretory pathway.
Results and Discussion
Following protein aggregation in the ER at single cell
level
When deleted of the CH1, Ig-m chains display a strong tendency
to become detergent insoluble and form RB [9]. To follow the
biogenesis of RB in vivo, we inserted the Halo tag between the
variable and the second constant domain of mDCH1. Halo-mDCH1
oligomerized and displayed detergent solubility similar to its
untagged counterpart (Figure 1, inset). This behaviour suggests
that even in the oxidising ER environment the Halotag, which
contains two free cysteines, does not form aberrant intra- or inter-
chain disulphide bonds, as confirmed also by the electrophoretic
mobility of an ER-located Halotag alone under reducing and non-
reducing conditions (Figure S1). We thus investigated how Halo-
mDCH1 aggregates grow in living cells by designing fluorescent
pulse-chase experiments. The rationale of these assays is to use
sequentially differently coloured ligands (TMR and R110) to
differentially label pre-existing ‘old’ molecules and newly made
‘young’ ones. HeLa cells expressing Halo-mDCH1 were labelled
24 hours with the red ligand (TMR) and washed before addition
of the green ligand (R110). After different time intervals, cells were
fixed and analysed by confocal microscopy. As the incubation time
with the R110 ligand increases, green staining becomes progres-
sively more intense (Figure 1). When protein synthesis was blocked
by the addition of cycloheximide 2 hours before and 4 hours
during the treatment with the second ligand, no green staining was
detectable. This confirmed that all the pre-existing molecules were
labelled with the red ligand and that no ligand exchange between
molecules occurs in living cells. Hence, our labelling protocol can
be used to discriminate between pre-existing and newly synthe-
sized molecules. After 4 hours, green staining almost completely
co-localized with the pre-existing RB. As synthesis continued,
bigger yellowish dots became evident, consistent with the
accumulation of newly made molecules next to pre-existing
aggregates, which progressively grew in size. At later times, a
green circle could be observed around most pre-existing red
aggregates: these onion-like structures imply that roundish deposits
of pre-existing molecules grow by sequential addition of layers
containing newly made proteins. Together with the old growing
aggregates, new green small dots can be observed at later times,
probably representing new seeds of protein condensation. Very
few red-only aggregates can be seen, indicating that most pre-
existing structures act as seeds. We measured the increase in size of
the aggregates after 24 hours of growth in the presence of the
green ligand: we observed a relative diameter increase of about
16% (Figure 2A, upper panel). As a control, no difference in the
diameter of the aggregates was observed when cells were
incubated simultaneously with both red and green ligands
(Figure 2A, lower panel). The possibility of detecting RB by
Immunofluorescence correlates with the accumulation of mDCH1
chains in the detergent insoluble fractions. These derive from the
condensation of proteins that fail to be degraded by ERAD [9,14].
Interestingly, young molecules distribute into soluble and insoluble
fraction as the old ones, indicating that independently on the
aggregation-step the Halo-mDCH1 molecule reaches equilibrium
between soluble and insoluble species (Fig. 2B). Hence also the
smaller green dots observed in fluorescence contain insoluble
molecules.
Next, we analysed the movement of Halo-mDCH1 aggregates by
tracking the individual RB in living cells by confocal live-cell
microscopy (Figure 3A–B). For each of the 115 tracks extracted
from 8 movies we measured the mean-square displacements
(MSD) as function of time (Figure 3C) and we fitted the first 20
points of the MSD curves with a model for anomalous diffusion,
MSD=4Dt a to obtain estimates for the short-term diffusion
coefficient D and for the anomalous diffusion exponent a. In
general, the tracks displayed anomalous subdiffusion, representa-
tive of constrained motion, with an average anomalous exponent
a=0.7460.02 and average diffusion coefficient
D=0.004560.0005 mm2/s. This value is significantly lower than
the diffusion coefficients of soluble ER proteins [29–32], further
confirming that Halo-mDCH1 clusters display constrained mobil-
ity. Interestingly, RB diffuse with a similar anomalous exponent
independently of their size, while as expected larger (and
potentially older) clusters displayed a reduced diffusion coefficient
(Figure 3D). We also observed a few small clusters moving
directionally (blue arrowed in Figure 3B), suggesting that the
microtubule network might play a role in the dynamic behaviour
of the clusters. We therefore quantified the mobility of the clusters
following the depolymerization of microtubules. Upon treatment
with Nocodazole the Halo-mDCH1 clusters displayed comparable
size to the untreated samples, but their diffusion coefficients were
0.5x smaller on average (Figure 3E), confirming that the motion of
the clusters is at least partially associated to the microtubule
network.
Following the degradation of an ER resident protein
In the absence of Ig-L, orphan ms are retained in the ER via
interactions with BiP [7]. After a lag that varies amongst different
substrates and/or cell types, they are retro-translocated into the
cytosol and eventually degraded by proteasomes [33–35]. Like its
untagged counterpart, Halo-ms is also retained in the ER, as
indicated by its co-localization with the ER chaperone PDI
(Figure 4A). Also in this case, the Halotag does not interfere with
oligomer formation or solubility of the tagged protein (Figure 1,
inset).
The standard approach to study protein degradation is based on
radioactive pulse and chase experiments [36], limited by the
restrictions of using radioactive isotopes and the difficulties in
analysing the phenomenon at the single cell level. The use of
cycloheximide chases [37] is restricted to short-lived proteins, since
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Figure 1. Halotag can be used to follow the aggregation/condensation of a protein in the ER. HeLa cells expressing Halo-mDCH1 were
labelled for 24 hours with the red TMR ligand (5 mM) in complete medium. After extensive washings, cells were incubated with the green ligand R110
(5 mM) for the indicated times. To control saturation, cells were treated with cycloheximide (0.5 mM) for the last 2 hours of the first TMR incubation,
and then during the incubation with R110 for 4 hours. Cells were then fixed in paraformaldheyde and analyzed by confocal microscopy. Images are
shown as confocal slices. With the progression of the chase, the green signal co-localizes with the pre-existing red signal and newly formed
aggregates (only green) can be visible. Pre-existing red aggregates grow by apposition of newly synthetized proteins which can be labeled in green.
(Bar: 5 mm). Single channel signals in gray scale are shown for the thumbnails (Bar: 1 mm). Inset: HeLa cells transiently expressing Halo-mDCH1 or Halo-
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prolonged inhibition of protein synthesis can affect cell proteostasis
[38]. For ERAD substrates retrotranslocation and degradation are
often monitored by cell fractionation, deglycosylation or ubiqui-
tination, and more recently exploiting split GFP- or Venus-based
dislocation assay [39,40]. Here we propose the use of Halotag to
follow ER proteins degradation.
We first analysed whether the presence of a Halotag with or
without a covalently bound ligand influenced ms degradation in
HeLa transfectants (Figure 4B). To this aim, cells transfected with
ms or Halo-ms were pulsed for 10 min with
35S. Where indicated,
cells were treated with TMR before (16 hours) and during the
radioactive pulse. Cells were then chased for different time points
in a medium without TMR or radioactive amino acids and lysed
ms were lysed, and aliquots from soluble (s) and insoluble (i) fractions resolved under non-reducing conditions on a 3–8% polyacrylamide gradient gel.
Nitrocellulose membranes were decorated with anti-m. Bands indicated with 1 represent monomeric proteins, while bands indicated with 2 represent
homodimers.
doi:10.1371/journal.pone.0108496.g001
Figure 2. Visualising the growth of RB. A Quantification of cluster growth by pulse-chase. Images were acquired as described above and analyzed
with custom-written Matlab routines to quantify the size of the clusters in the two channels. When the two ligands are added in sequence (with a
24 hours chase) an average 16%+/23% (SEM) increase in the cluster size is observed, while no difference in size can be measured when the two
ligands are added simultaneously. For the pulse and chase experiment 9 cells and 99 clusters were examined. For the simultaneous addition of the
two ligands 9 cells and 101 clusters were analyzed. Bar: 5 mm. B Distribution of old and young Halo-mDCH1 molecules. HeLa cells transiently expressing
Halo-mDCH1 were subjected to fluorescent pulse-chase assays: 24 hours with the TMR ligand and 24 h with the non-labelled ligand (TMR+black) or
24 hours with non-labelled ligand and 24 hours with the TMR ligand (black+TMR). Halo-ligands were used at 5 mM. Aliquots of soluble (s) and
insoluble (i) material were then resolved under reducing conditions on a 10% polyacrylamide gel. After transferring to nitrocellulose, the signal of the
TMR ligand was collected using fluorescence technology by FLA900 Starion. Densitometric quantifications are shown on the right. Average of 3
independent experiments +/2 standard deviation.
doi:10.1371/journal.pone.0108496.g002
The Shining Life of ER Proteins
PLOS ONE | www.plosone.org 4 October 2014 | Volume 9 | Issue 10 | e108496
in detergent. The anti-m immunoprecipitates were resolved by
SDS-PAGE under reducing conditions and transferred to nitro-
cellulose. Gels were first developed for autoradiography and then
for TMR signal. As shown in Figure 4B, the degradation patterns
of ms and Halo-ms are very similar, almost one third of radioactive
ms present at time 0 being degraded after 4 hours of chase.
Importantly, the presence of the ligand itself did not interfere with
Halo-ms degradation. This is an important observation, since in all
likelihood ERAD substrates are at least partially unfolded before
being retro-translocated across the ER membrane and entirely
before entry into the proteasomal cavity. The presence of a folded
domain with covalently linked ligand could have impacted either
one or both steps in the disposal of an ER luminal substrate. No
other fragment containing the ligand can be seen in the blot (not
shown), making very unlikely the possibility that endoproteases
clipped the Halotag with the bound ligand off [41]. The
degradation of the protein can also be seen directly by following
the disappearance of the TMR fluorescence on the gel (red line in
the graph). The decay observed in fluorescence is more rapid than
the disappearance of the radioactive signal because in the 16 hours
of staining with the Halo ligand also older molecules (closer to the
dislocation-degradation steps) have been stained.
Taken together, these data show that the degradation of ERAD
substrates can also be followed directly monitoring the disappear-
ance of the TMR fluorescence.
The Halo tag can be used to follow protein secretion
ERp44 cycles between the ER and cisGolgi and plays key roles
in thiol-mediated protein quality control, redox homeostasis and
calcium signalling [13,42]. When expressed in mammalian cells,
ERp44 prevents secretion of Ero1 flavoproteins and Peroxiredoxin
4, ER resident proteins which lack KDEL or other known
localization motifs [12,43,44]. We inserted a Halotag between the
cleavable ERp44 leader sequence and its first active sequence.
Halo-ERp44 retained the subcellular distribution previously
described for HA-tagged or untagged ERp44 [6], co-localizing
mostly with the ERGIC marker ERGIC-53 and much less with
GM130, a cisGolgi resident (Figure 5A). Halo-ERp44 can be
easily visualized in vivo, staining cells with TMR (Figure 5A) or
R110 (not shown). Moreover, Halo-ERp44 was as active as HA-
ERp44 in retaining excess Ero1a (Figure 5B). Note how Western
Figure 3. Live-imaging of ER protein aggregation. A HeLa cells expressing Halo-mDCH1 were labeled for 24 h with 5 mM TMR. Living cells were
then imaged by confocal microscopy at a frame rate of 2 images/s. B Aggregates display a heterogeneous dynamic behavior with some clusters
moving directionally (orange arrowhead) and others showing confined diffusion (blue arrowhead). C We tracked individual clusters in 8 cells and we
selected tracks that were longer than 150 frames (115 tracks) and we plotted individual MSD curves (orange thin lines) and their average (thick line).
Treatment of cells with 0.3 mg/ml Nocodazole for 15 hours (blue lines) decreased of the mobility of the aggregates. D The diffusion coefficient D and
the anomalous exponent a were calculated from the MSD curves obtained from the untreated samples and plotted against the estimated diameter
of the clusters. On average we measured a= 0.7460.02 and average diffusion coefficient D= 0.004560.0005 mm2/s. A value of a,1 is representative
of anomalous subdiffusion, probably due to obstacles constraining the mobility of the clusters. While the anomalous exponent did not seem to
depend on the cluster size, the diffusion coefficient was found to inversely correlate with the particle diameter. E We compared the distribution of
measured particle sizes, diffusion coefficients and anomalous exponents for the untreated and the Nocodazole treated samples: the diffusion
coefficient was the only parameter significantly affected by the disruption of the cytoskeleton (error bars: Mean 6 SEM).
doi:10.1371/journal.pone.0108496.g003
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blots can be simultaneously stained with ligands and different
antibodies emitting at different wavelengths, providing high
quality, elegant images. The intracellular retention of ERp44
relies on its C-terminal RDEL motif [6]. We previously showed,
using 35S radiolabeling [6], that deletion of the RDEL motif leads
to rapid ERp44 secretion. As expected, also Halo-tagged
ERp44DRDEL is massively secreted (Figure 5C), indicating that
tagging does not interfere with folding or trafficking of the protein.
The small molecular weight shift between intra- and extra-cellular
Halo-ERp44DRDEL is due to O-glycosylation [45]. The velocity
of secretion can be studied by using a protocol that resembles the
35S pulse and chase technique. HeLa cells transiently transfected
with Halo-ERp44DRDEL were labelled with R110 ligand
overnight. After several washes, the cells were incubated with a
fresh medium without the ligand and the secreted material was
then collected at different time points and analysed by SDS-
PAGE. Consistently with our previous data, the pool of labelled
Halo-ERp44DRDEL is completely secreted after 2 hours of chase,
the curve reaching a plateau. On the contrary, the signal detected
with anti-Halo antibodies (and hence representing labelled and
non-labelled secreted ERp44DRDEL) kept steadily increasing, due
to the addition to the release new molecules that are synthetized
during the chase. Thus, the Halotag labelling is a valid alternative
to the use of radioisotopes or cycloheximide treatment for studying
protein secretion. Altogether our data indicate that the Halotag
can be safely used to tag and follow an ER chaperone without
disturbing its regulatory properties.
Concluding Remarks
A significant advantage of the Halo domain is its ability to
covalently bind ligands with tailored features. In this study, we
exploited this property to visualise and quantify the traffic,
condensation and degradation of different proteins within the
early secretory pathway. First, we showed that the Halo moiety
can correctly fold also in the oxidizing environment of the ER
without forming aberrant intra- or inter-chain disulphide bonds.
Moreover, no significant differences have been observed between
ER-localized and cytosolic Halo for what concerns binding to its
ligands (not shown). Our data also demonstrated that appending a
Halo domain to different proteins had minor if any effects on the
degradation, secretion or localisation of the resulting chimeras.
Therefore, we could follow the fate of different proteins in the
secretory pathway, without utilising radioactive isotopes or
cycloheximide.
The most novel aspect of our work is the use of the Halotag
technology to determine how potentially harmful protein deposits
form and grow in the secretory pathway. We show here that
aggregates formation over time proceeds as deposition of newly
made proteins on a pre-existing condensation core, resulting in a
progressive increase of the clusters size. In this external shell of the
aggregates, no mixing between new and old material is observed,
suggesting that mDCH1 clusters are therefore rather ‘‘viscous’’ and
grow mostly on the surface. However, given the limited resolution
of confocal microscopy (200 nm laterally and 700 nm axially), we
Figure 4. Exploting Halotag to study ERAD. A Halo-tagging does not alter the localization of unassembled Ig-ms. HeLa cells were transiently
transfected with ms or Halo-ms as indicated, fixed with PFA and stained with antibodies specific for PDI or Ig-m. In this experiment, transfection
efficiency was about 25%. Bar: 5 mm. B The Halotag with or without bound ligand does not interfere with ms degradation. 48 hours after transfection,
HeLa cells expressing ms or Halo-ms cells were pulsed for 10 minutes with
35S aminoacids and chased in the presence of 5 mM DTT for the indicated
time points, to accelerate degradation [35]. One sample (Halo-ms+ligand) was pre-treated with TMR (2.5 mM) before and during the radioactive pulse.
Aliquots from the lysates corresponding to 106 cells for each time point were precipitated with anti-m, resolved under reducing conditions and
transferred to nitrocellulose membranes which were first developed for the 35S signal and then for TMR fluorescence (532 nm). Densitometric
quantification was performed by ImageJ. The graph shown in the bottom panel represents the percentage of the total m present at time 0 remaining
at individual times.
doi:10.1371/journal.pone.0108496.g004
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cannot determine if the newly deposited material can penetrate in
the nucleation core of the RB.
By using live-cell imaging we also shed light on the mobility of
Halo-mDCH1 clusters. Our data indicate that, as expected, RB
have on average a diffusion coefficient much lower than soluble
ER proteins. Moreover, the mobility of big clusters is lower than
that of small ones. A subset of RB shows a directional movement,
likely due to microtubule transport. Accordingly, inhibiting
microtubules decreased RB diffusion coefficient, indicating a
partial role of microtubules in determining RB movements. Very
interestingly, both small and big clusters displayed constrained
mobility, which was not affected by Nocodazole. This observation
suggests that an important constraining factor could be the ER
membrane itself.
Figure 5. Halotag does not influence the function or localization of ERp44. A Halo-tagging does not alter the localization of ERp44. HepG2
cells were transiently transfected with Halo-ERp44 and pre-treated with TMR ligand (10 nM O/N) before fixation and staining with antibodies specific
for ERGIC-53 or GM130 as markers of ERGIC or Golgi). Images were acquired with a 60X objective on an Olympus inverted fluorescence microscope
and subjected to deconvolution. Single channel images and the merge are shown. Bar: 5 mm. B Halo-ERp44 retains Ero1a efficiently. Hela cells were
transiently transfected with Halo-ERp44 and HA-ERp44 (alone or in combinations with Ero1a as indicated) 48 hours after transfection cells were
washed and incubated for 4 hours in OPTIMEM. One sample was treated with TMR before and during the secretion. The spent media and cells were
collected. The lysates corresponding to 105 cells (lanes 1–4) and the TCA precipitated supernatants of 5 times as many cells (56105, lanes 5–8) were
resolved under reducing conditions. Membranes were decorated with anti-Halo (blue signal), anti-HA (white signal), anti-Ero1a (green signal) and
TMR fluorescence (red). Halo-ERp44 can be expressed and visualized by TMR staining. No significant differences were detected between Halo-ERp44
and HA-ERp44 in terms of function (Ero1a retention). C Secretion of ERp44DRDEL is not impaired by appending a Halotag. HeLa transfectants
expressing Halo-ERp44 or Halo-ERp44DRDEL were incubated with OPTIMEM. After 4 hours, aliquots of lysates and supernatants (corresponding to
105 cells) were resolved under reducing conditions and the blots decorated with anti-ERp44. As HA-ERp44 DRDEL [6], Halo-ERp44 DRDEL is massively
secreted implying that the tag does not interfere with folding/secretion. D Hela cells transiently expressing Halo-ERp44DRDEL were incubated
overnight with the R110 ligand (35 nM), washed and incubated in OPTIMEM (without the Halo-ligand) for the indicated time points. Supernatants
corresponding to 5*106 cells were concentrated by TCA precipitation, resolved under reducing conditions and the TMR signal collected using a
fluorescent analyzer. The nitrocellulose filters were then decorated with anti-Halo antibodies. The intensities of the R110 fluorescent ligand and anti-
Halo signals were quantified by densitometry using the ImageJ software and normalized to the value after 15 minutes of secretion. The graph shows
the average of 2 independent experiments +/2 standard deviation.
doi:10.1371/journal.pone.0108496.g005
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Numerous questions remain to be answered: do different seeds
coalesce together? What determines their size? What is the
structural organization of these clusters? If their content is viscous,
how does it distribute concentrically? How do cells dispose of RB?
Extending the techniques described herein to super-resolution
fluorescence microscopy could allow answering many of these
relevant issues.
Given the importance of protein aggregates, granules and
clusters in storage diseases and also other regulatory processes
[46,47] our results describe a powerful tool for better visualizing
and describing in vivo these events, being able to discriminate
between old and young molecules in the same aggregate. Thus,
this strategy is useful in order to reveal important mechanistic
insights in the pathophysiology of ERSD and other disorders
caused by proteotoxicity.
Materials and Methods
Reagents
Chemicals were from Sigma (St Louis, MO), unless otherwise
indicated. Monoclonal anti-myc (9E10 clone) and anti-GM130
were used previously as described [48]. Polyclonal anti-PDI was a
kind gift of Dr. Ineke Braakman (Utrecht, NL); goat anti-mouse
IgG and IgM and anti-rabbit IgG (H+L) Alexa Fluor 700, 647,
546 and 488 were from Invitrogen Molecular Probes (Eugene,
Oregon, USA); rabbit polyclonal anti-m chain was from Zymed
(San Francisco, CA). Cell permeant ‘‘no wash’’ TMRDirect and
R110Direct ligands, and HaloTag Amine O4 ligand were from
Promega (Promega Medison, WI).
Plasmids construction
Vectors for the expression of HA-ERp44 and ERp44 no tag
were previous described [48]. To obtain Halo-ERp44, ERp44 no
tag was cleaved form pcDNA3.1(-) vector by XhoI and KpnI and
inserted in pBlueScript II KS (+). A SgfI (GCG AT.CGC)
(Promega Madison, WI) site was inserted after the leader sequence
cutting site by PCR (p44sgfI Fw and p44sgfI Rv primers). The
PCR product was re-inserted in pcDNA 3.1 (-) vector by XhoI and
KpnI. In pHTN HaloTag CMV-neo Vector, Halotag was
mutagenized inserting a Sgf I site at the N terminal extremity by
PCR (pHTN SgfI Fw and pHTN SgfI Rv primers) (Promega
Medison, WI). Both the mutated constructs were digested by SgfI
and purified by Wizard SV Gel and PCR Clean-Up System
(Promega Medison, WI). Halo-ERp44 tagged was obtained by
digestion by SgfI and ligation at 16uC over night from the
sequence previously purified from agarose gel. The direction of the
Halotag insertion was ascertained by SmaI digestion and the
construct was sequenced (Primm s.r.l., Milan, Italy).
Halo-ERp44 DRDEL was obtained with digestion and ligation
from the sequences of Halo-ERp44 and HA-ERp44 DRDEL: the
1007 Kbp fragment obtained by digestion of the plasmid HA-
ERp44 DRDEL pcDNA3.1(-) with HindIII was exchanged with
the one obtained from Halo-ERp44 pcDNA3.1(-) and checked by
sequencing.
HaloRDRDEL was obtained by two sequential PCR starting
from HaloERp44 construct. The first PCR was done to amplify
Halo tag fragment (primers FW: ACGACTCACTATAGGGA-
GAC; RV: TTTTTTGGGGTACCTTATGCGGCCGCACC-
GGTGTTATCGCTCTGAAAGTAC). The PCR product was
inserted into pcDNA3.1- vector by XbaI, KpnI digestion. The
obtained construct was then processed by PCR to insert RDRDEL
ER retention motif (primers FW: AGCGATAACACCGGTAGG-
GATCGAGATGAGCTTTAAGGTACCAAGCTT; RV: AAG-
CTTGGTACCTTAAAGCTCATCTCGATCCCTACCGGTG-
TTATCGCT). The construct was fully sequenced by Primm s.r.l.
Vectors for the expression of mS and mDCH1 were previously
described [8]. In pHTN HaloTag CMV-neo Vector, Halotag was
mutagenized inserting Nru site at N terminal extremity and NotI
site at C-terminal extremity by PCR. A pRS316 vector [49]
mDCH1 with cherry positioned after the VH and the pHTN
HaloTag PCR product were digested by Nru and NotI, purified
by Wizard SV Gel (Promega Medison, WI) and ligated to obtain
pRS316 vectors carrying VH-Halo-CH2 etc construct. This plas-
mid and pcDNA3.1(+) vectors carrying mS and mDCH1 were
digested by EcoRI and NotI to obtain respectively the VH-Halo
and the CH1-CH4 and the CH2-CH4 moieties, purified by Wizard
SV Gel (Promega Medison, WI) and ligated to obtain pcDNA3.1
(-) vectors carrying mS-Halo and mDCH1-Halo. Halo Tag insertion
direction was screened by EcoRI and XhoI digestion and checked
by sequencing.
Oligonucleotides
The following oligonucleotides were obtained from Primm s.r.l.
Milano, Italy):
p44SgfI Fw, CCTGTAACAACTGAAATAGCGATCGCTG-
AAATAACAAGT;
p44SgfI Rv, ACTTGTTATTTCAGCGATCGCTATTTCA-
GTTGTTACAGG;
pHTN SgfI Fw, GCCGCGATCGCTGAAGCAGAAATCG-
GTAACTGGCTTTCCATTC;
pHTN SgfI Rv, GGAAGCGATCGCGTTATCGCTCTG.
Cell culture, transfection and immunofluorescence
All the cell lines were obtained from ATCC and cultured and
transfected by PEI (Polyethyleneimene, Polysciences inc. War-
rington, PA) as previously described [50]. HepG2 cells were
transfected by Fugene HD transfection reagent from Promega
Corporation (Promega Medison, WI) following the manufacturer
instructions.
For immunofluorescence analyses, cells were plated on 15 mm
glasses and transfected. 48 hours after transfection cells were fixed
with 4% PFA and processed as previously described [6]. For
visualization with Halo-ligands, cells were treated O/N with the
membrane permeable ligands TMR or R110 (both used at
10 nM). Samples were analyzed with a 60X objective on an
Olympus inverted fluorescence microscope (model IX70)
equipped with a quadriband dicroic filter (Sedat Quad, Chroma)
with DeltaVision RT Deconvolution System (Alembic, HSR,
Milano). After deconvolution, images were processed with Adobe
Photoshop CS4 (Adobe Systems Inc.).
Western blot
For Western blot assays, HeLa cells were detached by
trypsinization and washed once in ice-cold phosphate buffered
saline (PBS) and once in PBS with 10 mM N-ethylmaleimide
(NEM) to block disulfide interchange [6]. Cells were then lysed in
150 mM NaCl, 1% NP-40, 0.1% SDS, 50 mM Tris HCl pH 8.0
(RIPA) containing 10 mM NEM and protease inhibitors for
20 min on ice. Aliquots of the postnuclear supernatants were
analyzed by SDS PAGE and western blotting with monoclonal
anti-ERp44 [6], anti-HA or polyclonal anti Halo (Promega).
Signals were detected by infrared technology by FujiFilm (FLA
9000) (FujiFilm Life Science, Tokyo, Japan).
Lysates of HeLa cells transiently transfected with Halo-ms or
Halo-mDH1 were produced as described [8].
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Radioactive pulse and chase
Cells were incubated for 30 min in DMEM without methionine
and cysteine supplemented with 1% dialysed FCS, pulsed with
35S-labeled amino acids (200 mCi/9*106 cells) (Easy Tag, Perkin
Elmer), washed and chased in complete medium for the indicated
times. After different times, cells were treated with 10 mM NEM
and lysed in RIPA as described [48]. Immunoprecipitates were
resolved on SDS–PAGE under reducing conditions, transferred to
nitrocellulose and membranes visualized by autoradiography with
FLA900 Starion (FujiFilm Life Science, Tokyo, Japan). Subse-
quently, the red signal form TMR was visualized with infrared
technology. Densitometric quantifications of the signals were
performed with ImageJ.
Confocal microscopy analysis: fluorescent pulse chase
For fluorescent pulse and chase experiments, Hela cells were
seeded on 25 mm glasses before transfection with Halo-mDCH1.
The minimum incubation time necessary to have a signal in IF in
our system with the ‘‘no-wash’’ TMRDirect ligand (5 mM) was
1 hour. However, in order to be sure to have completely saturated
all the pre-existing molecules in the cells, 24 hours after
transfection cells were stained for 24 hours with TMR (5 mM) in
complete medium, extensively washed with PBS and then
incubated with R110 (5 mM) in complete pre-warmed medium.
After different chase times, cells were fixed in PFA, glasses
mounted in glycerol and analyzed with a 60X objective with a
Leica TCS SP2 Laser Scanning Confocal equipped with a spectral
detector (Alembic, Ospedale San Raffaele, Milano, Italy). The
green channel was excited with a 488 nm laser and, in order to
avoid overlapping of the red channel, only the green emission
spectra from 495 to 535 was acquired. The red channel was
instead excited with a 543 laser and the emission spectra acquired
was from 570 to 640 nm of wavelength. A single optical section,
centered on the focal plane corresponding to the maximum size
and brightness of the RB clusters was acquired for the
quantification of the growth of the clusters. The size of the
clusters was evaluated from the confocal images with a custom-
written routine in Matlab, which allows the user to select the
isolated clusters and plot the fluorescence intensity profile along
the diameter of each cluster for both the green and the red
channel. The diameter of the clusters is then measured as the full
width at half maximum of the intensity profile and the relative
cluster size increase is calculated as (dg–dr)/dr where dg and dg are
the cluster diameters measured in the green and in the red channel
respectively.
Confocal microscopy analysis: Live cell tracking of
individual clusters
For live-imaging experiments, HeLa cells were seeded and
transfected as above. 24 hours after transfection cells were labeled
with 5 mM TMR ligand for 24 hrs. For Nocodazole treatment
cells were incubated 9 hours with the TMR ligand 5 mM and
15 hours with 5 mM TMR ligand and 0.3 mg/ml Nocodazole.
Cells were subsequently visualized with a Leica TCS SP5 Laser
Scanning Confocal Microscope in phenol-free DMEM at 37uC
and 5% CO2. A 543 nm laser was used for the excitation and the
fluorescent light emitted from the sample was acquired with a 63x
NA 1.4 oil immersion objective in the spectral window ranging
from 560 nm to 644 nm. Time-lapse imaging was performed on
individual cells by acquiring an image every 0.5 s seconds for 300
frames. We verified that no excessive photobleaching would
perturb single particle tracking, by repetitive imaging of fixed
samples using the same conditions as above: individual TMR
molecules undergo photobleaching after more than 1000 frames
on average, longer than our total acquisition time (data not
shown).
To obtain tracking data on individual clusters, the time-lapse
experiments were analyzed with the TrackMate plugin in Fiji [51].
Briefly, approximately 15 randomly chosen clusters were selected for
each cell and tracked using the semi-automatic tracking tool in
TrackMate. Tracks were then analyzed with custom-written routines
in Matlab to quantify the MSD plot of each cluster. The first twenty
time-points of the MSD curves were then fit by MSD=4Dt a, to
obtain estimates for the short-term diffusivity D and for the
anomalous diffusion exponent a. The Matlab routines are available
at: https://github.com/shiner80/TM_export-ClustTrack.
Supporting Information
Figure S1 The Halotag can fold properly in the ER. A
HeLa cells were transfected with a cytosolic or an ER localized
Halotag. Cells were stained O/N with the TMR ligand 5 mM and
images acquired with an inverted microscope. Bar: 5 mm. B
Lysates of HeLa cells expressing the ER-localized Halotag were
loaded under reducing (R) and non-reducing (NR) conditions on a
3–8% polyacrylamide gradient gel. The Halo tag was detected
with a polyclonal anti-Halo antibody. Note that no mobility shift is
visible between the reducing and the non-reducing samples,
indicating that the ER-localized Halo tag does not contain intra-
chain or inter-chain disulfide bonds. CHeLa cells were transfected
with a cytosolic or an ER localized Halotag and stained O/N with
the TMR ligand 5 mM before lysis in RIPA buffer. Increasing
amounts of lysates were loaded on reducing SDS-PAGE. First the
signal of the TMR ligand was acquired; the filters were then
decorated with a rabbit anti-Halo antibody and the signal of the
secondary anti-Rabbit IgG antibody (Alexa 700) was then
acquired. Densitometric quantifications are shown in the graph.
Note that the signal of the TMR is much more linear and
quantitative than the signal of the anti-Halo antibody.
(TIF)
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